The QualityStocks Daily Tuesday, September 7th, 2021

Today's Top 3 Investment Newsletters

QualityStocks(MTL) $5.00 +56.25%

MarketBeat(SRZN) $9.90 +36.74%

OTCtipReporter(HBIS) $1.30 +34.02%

The QualityStocks Daily Stock List

Crescent Point Energy (CPG)

TopStockAnalysts, StreetAuthority Daily, MarketClub Analysis, MarketBeat, Marketbeat.com, Zacks, Dividend Opportunities, Daily Dividends, ProfitableTrading, Daily Trade Alert, Trades Of The Day, StreetInsider, Energy and Capital, Investing Daily, InvestorGuide, Stockhouse, The Street, Stocks To Watch, InvestorPlace, Wealth Insider Alert, Daily Wealth, Day Trade Alert, Wealth Daily, Top Pros' Top Picks, Schaeffer's, Investor Guide, Louis Navellier, Super Stock Picker, Street Insider, StockMarketWatch and The Wall Street Transcript reported earlier on Crescent Point Energy (CPG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Crescent Point Energy Corp. (NYSE: CPG) (TSE: CPG) (FRA: 016) is an independent exploration and production firm that is focused on the exploration, development and production of medium and light crude oil and natural gas reserves.

The firm has its headquarters in Calgary, Canada and was incorporated in 1994, on April 20th. It operates as part of the oil and gas extraction industry, under the energy sector. The firm has eight companies in its corporate family and serves consumers in the United States and Canada.

The company is focused on the development of high-return resource plays and growing its significant resource base in the United States and Canada. Its natural gas and crude oil properties and related assets are located in the states of Utah, Colorado, Montana and North Dakota, and the provinces of Manitoba, British Columbia and Alberta.

The enterprise’s main focus areas are the Flat Lake Torquay play in south-east Saskatchewan, which is an extension of the Three Forks play in South Dakota; and the Shaunavon and Viewfield Bakken resource plays in Saskatchewan. It also holds a portfolio of assets in the Canadian portion of the Williston Basin. The enterprise has net probable plus proved reserves of over 860 million barrels of oil equivalent.

The company recently announced its latest financial results which show a reduction in net debt. In addition to maximizing excess cash flow generation and enhancing its long-term sustainability and its asset portfolio, the company is also focused on maximizing shareholder value, which will encourage more investments into the firm.

Crescent Point Energy (CPG), closed Tuesday's trading session at $3.52, off by 2.2222%, on 1,413,396 volume with 3,190 trades. The average volume for the last 3 months is 1.411M and the stock's 52-week low/high is $1.04999995/$4.85500001.

Bellicum Pharmaceuticals (BLCM)

StockMarketWatch, MarketBeat, The Street, BUYINS.NET, Kiplinger Today, Marketbeat.com, Money Morning, Barchart, QualityStocks, StreetInsider, TraderPower, Stock Gumshoe, Traders For Cash Flow, TopStockAnalysts, Jason Bond, Investing Lab, Investing Futures, INO.com Market Report, Hit and Run Candle Sticks and MarketClub Analysis reported earlier on Bellicum Pharmaceuticals (BLCM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bellicum Pharmaceuticals Inc. (NASDAQ: BLCM) (FRA: BPXA) is a clinical-stage biopharmaceutical firm that is engaged in the discovery and development of new cellular immunotherapies for the treatment of solid tumors and hematological cancers.

The firm has its headquarters in Houston, Texas and was incorporated in 2004, on July 14th by David M. Spencer and Kevin M. Slawin. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector, in the biotech and pharma sub-industry. The firm has four companies in its corporate family and serves consumers in the United States as well as internationally.

The company is party to license and collaboration agreements with Baylor College of Medicine, Ariad Pharmaceuticals Inc., the University of Texas MD Anderson Cancer Center, BioVec Pharma, Agensys Inc. and Adaptimmune Therapeutics Plc.

The enterprise’s product pipeline comprises of an allogeneic T cell product candidate dubbed Rivo-cel, which is indicated for the treatment of inherited blood disorders and hematologic malignancies. The candidate has been designed to improve outcomes when administered after hematopoietic stem cell transplantation. It also develops a dual-switch GoCAR-T candidate dubbed BPX-603, which is in phase 2 clinical trials testing its effectiveness in treating solid tumors which express the human epidermal growth factor receptor 2 antigens. In addition to this, the enterprise is involved in the development of an autologous GoCAR-T candidate known as BPX-601, which is undergoing a phase 2 clinical trial evaluating its effectiveness in treating solid tumors that express prostate stem cell antigens.

The company recently entered into an international license agreement with the Texas MD Anderson Cancer Center. This move will allow for the expansion of its existing CaspaCIDe agreement with the latter party and afford the company more opportunities for expansion, which may have a positive influence on its growth and investments into the firm.

Bellicum Pharmaceuticals (BLCM), closed Tuesday's trading session at $3.02, off by 2.2654%, on 215,017 volume with 1,112 trades. The average volume for the last 3 months is 215,017 and the stock's 52-week low/high is $2.56999993/$8.18999958.

comScore Inc. (SCOR)

StreetInsider, MarketBeat, The Street, Street Insider, InvestorPlace, Daily Trade Alert, Barchart, The Motley Fool, MarketClub Analysis, Louis Navellier, QualityStocks, Zacks, internetnews, internet, BUYINS.NET, BestChartNow, Hit and Run Candle Sticks, AllPennyStocks, Money Morning, Penny Stock Buzz, Schaeffer's, SmarTrend Newsletters, StockMarketWatch, StreetAuthority Daily, TradersPro and Marketbeat.com reported earlier on comScore Inc. (SCOR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

comScore, Inc. (NASDAQ: SCOR) is an information and analytics firm that measures audiences, consumer behavior and advertising across media platforms.

The firm has its headquarters in Reston, Virginia and was incorporated in August 1999 by Gian Mark Flugoni and Magid M. Abraham. It serves consumers around the globe.

The company helps measure what individuals do as they interact with the digital world across various technology platforms and devices, such as desktop computers, televisions, tablets and smartphones. Its objective is to help clients monetize audiences globally. The company serves technology providers, agencies, brand advertisers, content owners, movie studios, television networks and digital publishers.

The enterprise provides ratings and planning services and products that include the Plan Metrix, which provides understanding of consumer lifestyle; the Video Metrix, which measures digital video consumption; and the Mobile and Media Multi-Platform Metrix, which measures apps and websites on tablets, smartphones and computers. Other ratings and planning products include the Total Home Panel Suite, which captures connected TV, OTT and IOT content consumption and device usage; and the comScore Campaign Ratings for verification of desktop and mobile video campaigns. In addition to this, the enterprise also provides analytics and optimization services and products that offer solutions for evaluation, optimization and planning of advertising campaigns.

The company recently entered into a new agreement with Cornerstone Media Group. Cornerstone intends to expand its offering to the local market space through the exclusive use of comScore’s TV ratings currency data. This move will bring in additional revenue into the company and help grow its consumer reach, which will be good for the company’s growth.

comScore Inc. (SCOR), closed Tuesday's trading session at $4.12, up 2.2333%, on 267,006 volume with 2,430 trades. The average volume for the last 3 months is 265,647 and the stock's 52-week low/high is $1.79999995/$5.25.

Orchard Therapeutics (ORTX)

StreetInsider, MarketBeat, BUYINS.NET, StockMarketWatch, MarketClub Analysis, Trades Of The Day and Daily Trade Alert reported earlier on Orchard Therapeutics (ORTX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Orchard Therapeutics Plc (NASDAQ: ORTX) (FRA: OT1A) is a biopharmaceutical firm that is focused on the development of gene therapies for severe and life-threatening rare ailments.

The firm has its headquarters in London, the United Kingdom and was incorporated in August 2018 by Andrea Spezzi and Nicolas Koebel. Prior to its name change, the firm was known as Orchard Rx Ltd. It operates as part of the pharmaceutical and medicine manufacturing industry, under the health care sector, in the biotech and pharma sub-industry. The firm serves consumers in the U.S., the United Kingdom and the European Union.

The company is party to a collaboration agreement with Pharming Group N.V., which entails conducting research, developing, manufacturing and commercializing an ex vivo autologous hematopoietic stem cell gene therapy which has been developed to treat hereditary angioedema.

The enterprise’s clinical development products include OTL-300, which is indicated for the treatment of transfusion-dependent beta-thalassemia; OTL-102, which has been developed to treat X-linked chronic granulomatous disease; OTL-103, which has been developed to treat Wiskott-Aldrich syndrome; OTL-200, which is indicated for the treatment of metachromatic leukodystrophy; and OTL-101, which has been developed to treat ADA-SCID (of adenosine deaminase-severe combined immunodeficiency). It also develops a gamma retroviral-based formulation dubbed Strimvelis, also for the treatment of ADA-SCID.

The firm’s strategic collaboration with Pharming N.V. affords both companies an opportunity to reinvent the treatment paradigm for hereditary angioedema by offering individuals living with this disorder a sustained therapy with a single administration. The treatment’s success is bound to have a positive effect, not only on the firm’s revenues but also on its growth and investments.

Orchard Therapeutics (ORTX), closed Tuesday's trading session at $2.93, even for the day, on 787,237 volume with 3,390 trades. The average volume for the last 3 months is 775,819 and the stock's 52-week low/high is $2.31999993/$9.07999992.

Titan Pharmaceuticals (TTNP)

QualityStocks, Real Pennies, StockMarketWatch, MarketBeat, BUYINS.NET, The Street, StreetInsider, SmarTrend Newsletters, Stock Analyzer, PennyStocks24, PickPennyStocks, OTCJournal, HotOTC, CoolPennyStocks, OTCtipReporter, Penny Pick Finders, FeedBlitz, Penny Stock Finder, PennyStockProphet, Canadian Microcap Report, Marketbeat.com, The Online Investor, Research Driven Investor, StockEgg, Research Driven Alerts, TraderPower, SmallCap Network, Stock Stars, StockOnion, InvestorPlace, StockOodles, Growing Stocks Reports, Michael Stone, DrStockPick, OTC Markets Group, CRWEFinance, VectorVest, Buzz Stocks, Wall Street Resources, Greenbackers, PennyStockScholar, Morning Stock Picks, OTC Picks, OTC Stock Review, Stockdigest Report, Penny Invest, SMS News Alerts, SmallCapInvestorDaily, PennyOmega, Barchart, Wealthpire Inc., PennyTrader, SecretStockPromo, Planet Penny Stocks and MonsterStocksPicks reported earlier on Titan Pharmaceuticals (TTNP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Titan Pharmaceuticals Inc. (NASDAQ: TTNP) (FRA: TN7) is a pharmaceutical firm that is focused on the development of therapeutics for the treatment of chronic ailments.

The firm has its headquarters in San Francisco, California and was incorporated in 1992, on February 7th by Louis R. Bucalo. It serves consumers across the globe.

The company is focused mainly on innovative treatment for certain chronic ailments for which steady-state delivery of a drug offers an effective and/or safety benefit. It operates through one segment, which oversees the development of pharmaceutical products. Its product development programs use the company’s long-term drug delivery platform, dubbed ProNeura. This drug delivery system comprises of a small solid rod fabricated from a drug substance and a mixture of EVA (ethylene-vinyl acetate).

The enterprise is focused on the development of two programs, namely, its Nalmefene Development program and the Kappa Opioid Agonist Peptide program. Its TP-2021 (kappa opioid agonist peptide) utilizes ProNeura technology to offer a non-addictive treatment for various types of pain. The enterprise also develops a buprenorphine implant dubbed Probuphine, based off of its ProNeura technology, which is utilized for the maintenance treatment of opioid use disorder in patients who are clinically stable. The implant has been approved for use in the European Union, Canada and the United States.

The firm’s TP-2021product, which recently concluded its in-vivo study, has demonstrated the potential to provide extended durability and effectiveness in the treatment of moderate to severe chronic pruritus. The success of this product will not only help extend the firm’s consumer reach and bring in additional revenue but also bring in more investors into the firm.

Titan Pharmaceuticals (TTNP), closed Tuesday's trading session at $2.11, off by 0.938967%, on 181,756 volume with 904 trades. The average volume for the last 3 months is 181,756 and the stock's 52-week low/high is $2.06999993/$8.85000038.

Mechel PAO (MTL)

StockOodles, MarketBeat, SmarTrend Newsletters, InvestorPlace, StockMarketWatch, BUYINS.NET, Money Morning, The Street, TopStockAnalysts, Daily Profit, Money Map Press, Marketbeat.com, Hit and Run Candle Sticks, Daily Markets, Short Term Wealth, BullRally, MadPennyStocks, CoolPennyStocks, Investopedia, HotOTC, Investment House, PennyStockVille, FNNO Newsletters, Dividend Opportunities, Daily Trade Alert, InvestmentHouse, StockEgg, Wallstreetlivechat, Trading Concepts, Trades Of The Day, TradersPro, TopPennyStockMovers, Streetwise Reports, StreetInsider, OilAndEnergyInvestor, StockRich, MonsterStocksPicks, Stock Stars, Stock Research Newsletter, Stock Market Watch, QualityStocks, WealthMakers, PennyInvest, AnotherWinningTrade and StreetAuthority Daily reported earlier on Mechel PAO (MTL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Mechel PAO (NYSE: MTL) (FRA: MHSG) (MCX: MTLR) is a holding firm that is focused on the power, steel and mining businesses in the United States, the Middle East, the Commonwealth of Independent States, Europe, Asia, Russia and internationally.

The firm has its headquarters in Moscow, Russia and was founded in 2003, on March 19. Prior to its name change in March 2016, the firm was known as Mechel OAO. It provides motor, rail and sea transportation services to 3rd parties and has a freight river port on the Kama River as well as freight seaports on the Sea of Azov and the Sea of Japan.

The company operates through the following segments: Power, Mining and Steel segments. The power segment is involved in generating and supplying heat power and electricity to the mining and steel segments and also sells a portion of heat power and electricity to the wholesale market while the mining segment produces chemical products like coal benzene, coal tar, coke, iron ore concentrate, iron ore, steam coal, metallurgical coal (anthracite, PCI and coking coal) and has coke, iron ore and coal production facilities in China. On the other hand, the steel segment is involved in the sale of high-value added metal products like ferrosilicon, hardware, stampings and forgings; stainless and carbon flat steel products, a wide range of steel grades and semi-finished steel products as well as metal products, such as rails, beams, structural shapes and wire products. The majority of the company’s revenue is generated from its steel segment.

The firm recently reported its financial results for 2021’s first quarter, which show an improvement due to increased prices for the product range of its steel and mining segments. The firm is now focused on restoring planned production levels, maintaining operations and growth, which will boost investments into the firm.

Mechel PAO (MTL), closed Tuesday's trading session at $5, up 56.25%, on 11,319,648 volume with 43,580 trades. The average volume for the last 3 months is 10.967M and the stock's 52-week low/high is $1.28999996/$5.19000005.

Adaptimmune Therapeutics (ADAP)

MarketClub Analysis, StockMarketWatch, MarketBeat, QualityStocks, BUYINS.NET, The Street, StreetInsider, Marketbeat.com, Money Morning, Schaeffer's, TraderPower, Zacks, Street Insider, TradersPro, Trades Of The Day, Wealth Insider Alert, InvestorPlace, INO.com Market Report, Daily Trade Alert and SmallCapNetwork reported earlier on Adaptimmune Therapeutics (ADAP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Adaptimmune Therapeutics PLC (NASDAQ: ADAP) (FRA: 473A) is a clinical stage biopharmaceutical firm that is engaged in the provision of new cell therapies which cater mainly to patients with solid tumors in the U.K. and the U.S.

The firm has its headquarters in Abingdon in the United Kingdom and was incorporated in 2008 by Helena Katrina Tayton-Martin, James Julian Noble and Bent K. Jakobsen. It serves consumers across the globe.

The enterprise is party to a co-commercialization and co-development agreement with Universal Cells Inc.; a strategic alliance agreement with MD Anderson Cancer Center; 3rd party collaborations with the National Center for Cancer Immune Therapy in Denmark, Alpine Immune Sciences Inc. and Noile-Immune Biotech Inc. as well as a license and collaboration agreement with GSK.

The company’s product pipeline is made up of ADP-A2M4, which is currently in phase 1 clinical trials for MRCLS (myxoid round cell liposarcoma) indications, synovial sarcoma, gastric and esophageal, non-small cell lung, ovarian, neck and head, melanoma and urothelial cancers; phase 2 clinical trials with SPEARHEAD 2 for head and neck cancer and phase 2 clinical trials with SPEARHEAD 1 for MRCLS and synovial sarcoma. It also develops ADP-A2M4CD8, which is currently undergoing a phase 1 clinical trial for SPEAR T-cells, and has been indicated for the treatment of bladder, head and neck, gastroesophageal and lung cancers while ADP-A2AFP, has been indicated for hepatocellular carcinoma and is currently undergoing phase 1 clinical trials.

The firm’s preclinical data from its HiT induced complete regression in mouse models, which brings the firm a step closer to bringing new cell therapy products forward for clinical development and launch.

Adaptimmune Therapeutics (ADAP), closed Tuesday's trading session at $6.37, up 28.9474%, on 46,620,738 volume with 173,770 trades. The average volume for the last 3 months is 46.621M and the stock's 52-week low/high is $3.36999988/$10.9300003.

Sunstock, Inc. (SSOK)

QualityStocks, Stockgoodies, SizzlingStockPicks, Pennystockmania, POSstocks, Penny Stock Mobsters, WallstreetSurfers, Stock Commander, Journal Transcript, Winning Stock Plays, PennyStock Tweets, Damn Good Penny Picks, OTCtipReporter, Penny Pick Finders, Penny Picks, Buzz Stocks, Planet Penny Stocks, Profitable Trader Authority, StockOnion and PennyStockProphet reported earlier on Sunstock, Inc. (SSOK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sunstock, Inc. operates a coin store that buys and sells precious metal coins and also an asset-backed set of cryptocurrencies backed by gold, silver, and platinum. It operates one precious metals retail store under Mom’s Silver Shop in Sacramento, California. Sunstock pursues a “ground to coin” strategy. Thus, it secures and/or acquires mining assets and also rights to purchase mining production, and sells these metals mainly through retail channels through their own branded coins. Formed in 2012, Sunstock is headquartered in Sacramento, California.

Sunstock is moving ahead with “Triple 8”, precious metal asset-backed Crypto Tokens. The Company is redefining how the world conceptualizes and uses money with the pending launch of asset-backed cryptocurrencies, which are directly tied to the value of gold bullion. “Triple 8” provides a value proposition for investors and end-users of the token.

Sunstock’s plan is to become a pure gold play stock, with plans to own a complete Vertical Integration in the gold industry. Its intention is to acquire mineral rights and gold mining assets to complement its robust and growing gold distribution business. The Company anticipates acquisition prices in the $5,000,000 to $10,000,000 range. The mines it is considering are producing upwards of 60,000 ounces of gold annually.

Sunstock states that it is in talks to acquire or partnership with a number of assets that could potentially produce billions in revenue over 5-10 years. The Company is centered on projects that already own substantial amounts of unrefined – but already mined – gold ore.

Mr. Jason Chang is the Founder, Chairman, Chief Executive Officer and Investor Relations Officer of Sunstock, Inc. Mr. Chang has more than 20 years of hospitality management experience. He began his career in the hospitality industry in the family business operating several hotels throughout California.

Sunstock previously announced that it added to its existing precious metals sales and distribution strategy by targeting acquisitions in the gold mining industry. At the same time, It is working with its partners and advisors on a strategy to uplist to the OTC Markets Group’s OTCQB.

Sunstock, Inc. (SSOK), closed Tuesday's trading session at $0.8, up 31.1475%, on 15,646 volume with 26 trades. The average volume for the last 3 months is 15,646 and the stock's 52-week low/high is $0.012/$10.00.

ZIOPHARM Oncology (ZIOP)

The Street, MarketClub Analysis, INO.com Market Report, Investors Alley, StockMarketWatch, Greenbackers, StreetInsider, Contrarian Press, MarketBeat, Schaeffer's, Top Pros' Top Picks, SmallCapVoice, BUYINS.NET, Barchart, Investing Futures, Marketbeat.com, InvestorPlace, StreetAuthority Daily, GorillaTrades, Streetwise Reports, GreatStockPix, QualityStocks, Daily Profit, MonsterStocksPicks, TopStockAnalysts, TraderPower, Wall Street Resources, Wealthpire Inc., Weekly Wizards, DrStockPick, Dividend Opportunities, FeedBlitz, CRWEFinance, ChartAdvisor, BestOtc, Investment U, CRWEWallStreet, PricelessPennyStocks, Uncommon Wisdom, Trading Markets, TradersPro, Street Insider, StockOodles, Stock Stars, Stock Beast, Penny Stock Rumble, Seeking Alpha, InvestorsUnderground, PennyToBuck, PennyStockRumors.net, Xtremepicks, PennyOmega, MicrocapVoice, Jet-Life Penny Stocks, Jason Bond and SmallCap Network reported earlier on ZIOPHARM Oncology (ZIOP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

ZIOPHARM Oncology Inc. (NASDAQ: ZIOP) (FRA: WEK) is a biopharmaceutical firm that is focused on acquiring, developing and commercializing cell and gene based therapies for the treatment of graft-vs-host ailments and cancer.

ZIOPHARM Oncology Inc. serves consumers in the United States and was established on September 9, 2003. The firm has its headquarters in Boston, Massachusetts and is party to contractual arrangements with its licensing partners, both from abroad as well as in the U.S. who help fund the development of the firm’s product candidates.

ZIOPHARM Oncology Inc. is party to a cooperative development and research agreement with the National Cancer Institute, a patent license agreement with the same institute, a research and development agreement with the Anderson Cancer Center at the University of Texas and a license agreement with PGEN Therapeutics Inc.

ZIOPHARM Oncology’s product pipeline includes its Sleeping Beauty platform, which is based off of non-viral immune cell genetic engineering; Controlled IL-12, which stimulates IL-12 expression and helps an individual’s immune system attack the cancer cells; and a gene delivery system that regulates IL-12 production and treats adult patients with recurrent glioblastoma multiforme, known as Ad-RTS-hIL-12 plus veledimex.

ZIOPHARM Oncology Inc. partnered recently with TriArm Therapeutics, a cell therapy firm, for a clinical trial which will assess patient-derived CD19-specific CAR-T. This will make it the only study so far to focus on autologous non-viral CD19-specific CAR-T over in Taiwan, and is bound to attract a lot of attention, which will be good not only for the growth of both firms but also for their share prices.

ZIOPHARM Oncology (ZIOP), closed Tuesday's trading session at $2.2, up 33.3333%, on 64,572,634 volume with 147,570 trades. The average volume for the last 3 months is 64.222M and the stock's 52-week low/high is $1.25999999/$5.9499998.

MobileSmith, Inc. (MOST)

QualityStocks and Daily Trade Alert reported earlier on MobileSmith, Inc. (MOST), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

MobileSmith, Inc. is a leader in the digital health and mobile development sector. It provides operational improvement member-facing mobile application (app) services to the healthcare industry in the U.S. The Company helps its clients improve health outcomes, patient satisfaction and grow profit margins using its toolbox of proven mobile app technologies. OTCQB-listed, MobileSmith has its corporate office in Raleigh, North Carolina.

The Company is changing healthcare one app at a time through targeting the evident inefficiencies in the U.S. healthcare delivery model. Greater than 60 healthcare systems and organizations are partnering with MobileSmith Health to deliver a new healthcare experience and embrace the impact of technology as an agent of change. Fundamentally, MobileSmith is helping its clients meet their healthcare consumers where they are, on their mobile devices, to expand the reach of providers to modify behavior with apps that remind, educate, track, and also engage the patients that use them.

MobileSmith is focusing on select patient segments that struggle with areas such as medication adherence, discharge instruction compliance, and health literacy, and provide new unique digital patient experiences including indoor navigation and clinic “check-ins”, which directly improve critical patient satisfaction.

Via the use of MobileSmith Health Blueprints, hospitals and other healthcare organizations can customize their apps based on specific feature sets, workflow, branding, protocol, procedure and service line. This is while launching in as little as 90 days. MobileSmith’s latest Blueprints 3.0 offerings provide expanded mobile capabilities across the Company’s main applications: In-Network Apps, Perioperative Apps, and Patient Acquisition apps. Additional Blueprint 3.0 features include key mobile-specific functionality such as self-triage, remote check-in, wayfinding and EMR interoperability.

Previously, MobileSmith Health announced a collaboration with Kaweah Delta Medical Center on the release of a surgery app. This app provides patients and caregivers with timed notifications, digital trackers and interactive resources about what to expect before, during and after surgery. The Kaweah Delta Surgery App was developed using MobileSmith Health’s signature Blueprints.

MobileSmith Health also announced the launch of Perioperative Blueprints 4.0. The expanded app Blueprints include new functionality, which tailors the patient experience pre- and post-op with the introduction of “Peri,” which offers AI-based (Artificial Intelligence) interactions that elevates patient literacy with conversational interfaces, video, as well as images. EMR integration and new adherence tracking dashboards permit providers to readily assess risk factors for complications, cancellations or readmissions.

MobileSmith, Inc. (MOST), closed Tuesday's trading session at $3.5, up 42.8571%, on 8,578 volume with 6 trades. The average volume for the last 3 months is 8,578 and the stock's 52-week low/high is $1.00999999/$6.23000001.

Golden Valley Mines Ltd. (GLVMF)

We reported earlier on Golden Valley Mines Ltd. (GLVMF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Golden Valley Mines Ltd. concentrates on project generation and continues to evaluate opportunities to enhance its mining exploration property portfolio. The Company is able to increase its current assets via partner-funded option/joint ventures (JVs) and through its shareholdings in related entities. Golden Valley Mines is headquartered in Val-d’Or, Québec. The Company lists on the OTC Markets Group’s OTCQX.

Golden Valley Mines’ Assets/Related Entities include Abitibi Royalties, Inc., Val-D'or Mining Corporation, as well as International Prospect Ventures. The Company’s Options and JVs include the Centremaque Option.

The Company granted an option to O3 Mining (previously Alexandria Minerals Corporation) to acquire an 80 percent interest in the Centremaque Gold Prospect. O3 Mining may earn the 80 percent interest in Centremaque through issuing treasury shares to Golden Valley over a four-year period from date of signing.

Pertaining to Centremaque, a 5,200-meter drilling program is ongoing. Recent results include 18.8 g/t Au over 1.3 meters in O3-C-19-011; 5.30 g/t Au over 1.9 meters in O3-C-19-010, and 3.65 g/t Au over 2.25 meters in O3-C-19-008, and also 9.3 g/t Au over 6.0 meters, including 25.7 g/t Au over 1.9 meters in CAX-19-016.

Golden Valley Mines’ Options and JVs also include Eldorado Gold – ABG Joint Venture. Golden Valley Mines has a 70:30 JV with Eldorado Gold (previously Ingetra Gold) in the group of 9 properties (8 gold and 1 copper-zinc-silver) located in the AGB (Québec and Ontario).

Concerning its Assets/NSR'S and FCI'S, Golden Valley Mines has its Val-D'or Mining NSR. It entered into an option agreement between Golden Valley Mines and Val-d’Or Mining Corporation in April of 2017 regarding a group of properties situated in the Abitibi Greenstone Belt of North-Eastern Ontario and North-Western Québec. Furthermore, Golden Valley Mines has its Lac Barry Prospect FCI and NSR. It granted an option to Bonterra Resources to acquire an 85 percent interest in the Lac Barry Prospect.

The Company also has its Cheechoo Gold Prospect NSR. At present, it holds an NSR on the Cheechoo Gold Prospect that ranges from 2.5 percent - 4.0 percent depending on commodity prices. The Cheechoo Gold Prospect is 100 percent owned by Sirios Resources.

At the end of November 2020, Golden Valley Mines announced that it acquired ownership of 4,166,667 common shares in the capital of Val-d'Or Mining Corporation that were issued by the Issuer from its treasury at a deemed per share price of $0.13 for a total deemed value of $541,666.71. This is as partial and final satisfaction of consideration for a grant by Golden Valley of an option to the Issuer to acquire certain mineral property interests in accordance with the terms of an Amended and Restated Mining Option Agreement between the Issuer and Golden Valley dated November 28, 2019, which increased Golden Valley's security holding percentage by roughly 3.75 percent.

Golden Valley Mines Ltd. (GLVMF), closed Tuesday's trading session at $7.43, up 31.5044%, on 172,308 volume with 309 trades. The average volume for the last 3 months is 172,308 and the stock's 52-week low/high is $4.80999994/$8.09409999.

Home Bistro, Inc. (HBIS)

OTCtipReporter, Profitable Trader Authority, PennyStockScholar, PennyStockProphet, SmallCapVoice, StockOnion, QualityStocks, Penny Pick Finders, Buzz Stocks, Mega Stock Alerts and HotOTC reported earlier on Home Bistro, Inc. (HBIS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Home Bistro, Inc. is a provider of high quality, direct-to-consumer, ready-made gourmet meals. The Company provides these meals at www.homebistro.com, which includes meals inspired and created by celebrity “Iron Chef” Cat Cora. In addition, it provides restaurant quality meats and seafood by way of its Prime Chop www.primechop.co and Colorado Prime brands. Home Bistro has its head office in N Babylon, New York. The Company’s shares trade on the OTC Markets.

Home Bistro is a premier gourmet online meal delivery service that has been delivering meals since 2014. The Company’s broader growth strategy is to respond to increasing interest in its products and to widen its penetration of the markets it now serves in the United States.

Regarding its Premium Meats, its Prime Chop offers affordable All-American Premium Meats. These include Raw and Cooked offerings. Chop also offers Samplers, such as the Steak Lover's Sampler Assortment. Furthermore, it offers Soups as well as Desserts.

Home Bistro recently announced the phase one launch of its newly redesigned website at www.homebistro.com and the launch of its new marketing campaign. The Company stated that the next phase of additional enhancements to the site will be released periodically over the next few months

Home Bistro, Inc. (HBIS), closed Tuesday's trading session at $1.3, up 34.0206%, on 113,711 volume with 299 trades. The average volume for the last 3 months is 113,711 and the stock's 52-week low/high is $0.35010001/$3.

The QualityStocks Company Corner

Kaival Brands Innovations Group Inc. (KAVL)

The QualityStocks Daily Newsletter would like to spotlight Kaival Brands Innovations Group Inc. (KAVL).

  • Kaival Brands has recently begun in-house production of the revolutionary Bidi Pouch, with views towards commercializing it from September onwards
  • The Bidi Pouch will be targeted at the rapidly growing nicotine pouches market, which is forecast to be worth $32.8bn by the end of 2026
  • A recent peer-reviewed article in the American Journal of Public Health promoted vaping and smoke-free nicotine products as a “safer” alternative to combustible tobacco
  • Kaival Brands’ product portfolio is set to position the company to benefit from the ongoing shift in consumer demand

Kaival Brands Innovations Group (NASDAQ: KAVL) is a company that has rapidly garnered a reputation for fostering and incubating innovative companies into mature, dominant brands. As such, the success of the Bidi(TM) Stick, an innovative nicotine vaping device designed to provide adult smokers with a premium vaping experience and for which Kaival Brands operates as the sole distributor, comes as no surprise. The company has recently announced plans to broaden its product portfolio through the launch of the Bidi(TM) Pouch, a proprietary tobacco-free nicotine formulation packed in an easy-to-go plastic can, which will begin to go on sale as of September 2021 (https://ibn.fm/jYCUn) (https://nnw.fm/dOCl0).

Kaival Brands Innovations Group Inc. (KAVL) is focused on growing and incubating innovative and profitable products into mature, dominant brands. It aims to develop internally, acquire or exclusively distribute these products, helping them grow into market-share leaders by providing superior quality that is recognizable in their individual industries.

Formerly known as Quick Start Holdings Inc., the company changed its name to Kaival Brands Innovations Group Inc. (also known as Kaival Brands) in July 2019. Headquartered in Grant, Florida, the company commenced business operations on March 9, 2020.

Bidi™ Stick – Revolutionizing the Vaping Experience

On March 9, 2020, Kaival Brands entered into a partnership with Bidi Vapor LLC. The latter granted Kaival Brands exclusive global distribution rights for the innovative Bidi™ Stick.

Bidi™ Stick is a completely self-contained disposable product that is tamper-proof and recyclable. The innovative product is made from high-quality components and equipped with a long-lasting battery and class A nicotine. Its product engineering also includes a sensitivity control system, along with a proven mechanism designed to help identify and eliminate counterfeit products.

Available in 11 flavors, the Bidi™ Stick offers a premium vaping experience for adult consumers only. From its packaging design to its marketing strategies, Bidi Vapor makes sure that everything is compliant with government regulations.

On March 31, 2020, Kaival Brands partnered with QuikfillRx Digital as a digital service provider to help promote and commercialize the Bidi™ Stick. As a direct result of the partnership, Kaival Brands received back-to-back orders for the vaping device, totaling approximately $135,000, from sizable national convenience chains.

On September 8, 2020, the company announced that Bidi Vapor had submitted its Premarket Tobacco Product application (PMTA) to the U.S. Food and Drug Administration (FDA) for review. In total, over 285,000 pages of research, studies and surveys were submitted to support the application of Bidi™ Stick’s 11 variants.

“We are confident that, upon review, the FDA will authorize Bidi Vapor’s Bidi™ Stick for continued marketing in the United States,” Niraj Patel, President and CEO of Kaival Brands, stated in a news release (http://nnw.fm/unAyG).

Bidi Vapor is an industry leader in recycling – a position that was furthered through the creation of the Bidi Cares Initiative. The program encourages users to recycle their used Bidi™ Sticks instead of trashing them. As motivation, Bidi Vapor offers a free Bidi™ Stick for every 10 used devices recycled by a consumer. Kaival Brands is the exclusive recycling provider for the initiative.

Partnership Impact and Market Outlook

Bidi Vapor is a related party to Kaival Brands, as it is owned by Kaival Brands CEO Nirajkumar Patel. Patel is also the majority stockholder of Kaival Brands, placing both entities under common control.

The partnership has already had a positive impact on Kaival Brands, helping the company expedite growth, as evidenced by its Q2 financial results. According to Kaival Brands’ consolidated fiscal results for the quarter that ended on April 30, 2020, its revenues grew to approximately $22.5 million from no revenue in the same quarter of 2019. The company also scored a gross profit of $4.2 million for the three-month period. Net income was reported at $2.8 million for the quarter, compared to a net loss of about $4,000 in the second quarter of 2019. The company ended the second quarter of 2020 with a cash balance of $2 million (http://nnw.fm/44sq4).

The positive results are primarily an effect of Bidi™ Stick distribution amid the growing worldwide demand for high-quality vape products, as Patel explained in a news release. “Our focus now is to continue to increase revenues by increasing Bidi Vapor’s market share in the vaping industry,” he added.

Internationally, Kaival Brands has already taken steps to expand distribution of the Bidi™ Stick into Guam, Canada, the European Union, the United Kingdom, Australia and New Zealand.

To this end, the company has set up a market engagement and sales force to reach a higher volume of retail and wholesale customers. It also created a dedicated customer support team to provide high-quality service and an enhanced customer experience.

Kaival Brands is dedicated to developing innovative and viable options for adults who use tobacco and vape products and want a premium experience. The company wants to set higher standards to transform perceptions and elevate consumer experience in the vape and CBD industries, with a goal of increasing market share in the ever-growing vaping industry. In 2019, the reported global market for the vaping industry alone was $12.4 billion. These forecasts indicate a potential CAGR of 23.8% through 2027.

Cancellation of 300 Million Shares of Common Stock

In August 2020, the company canceled 300 million shares of common stock, marking a 52.1 percent reduction in its issued and outstanding shares of common stock (http://nnw.fm/W7s9T). Currently, the company’s outstanding common shares total 277,282,630. The cancelation was done in exchange for three million shares of Series A Preferred Stock. The Series A Preferred Stock cannot be converted before November 2023, barring any event that may trigger early conversion.

According to Patel, this move will benefit all shareholders and help maintain stability of the market pricing of remaining common stock. The overall goal is to increase value for long-term investors.

Management Team

Nirajkumar Patel is the CEO, CFO, President, Treasurer and Director of Kaival Brands and owner of Bidi Vapor LLC. In 2004, Patel received a Bachelor of Science in pharmaceutical sciences from AISSMS College of Pharmacy in Prune, India. He moved to the United States in 2005, and he continued his education at the Florida Institute of Technology, where he graduated in 2009 with a master’s degree in medicinal and pharmaceutical chemistry. He currently holds a Six Sigma Black Belt Certification.

Eric Mosser is the COO, Secretary and Director of Kaival Brands. Mosser attended Arizona State University, where he studied business management. In 2004, he graduated from Rio Salado College with an associate degree in applied science in computer technology.

Kaival Brands Innovations Group Inc. (KAVL), closed Tuesday's trading session at $7.46, up 30.6297%, on 260,503 volume with 1,864 trades. The average volume for the last 3 months is 260,419 and the stock's 52-week low/high is $2.73959994/$43.7999992.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX).

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has announced that its human clinical study HYPER-H21-2, which features LEXX’s patented DehydraTECH(TM)-processed cannabidiol (“CBD”), demonstrates up to a 23% decrease in blood pressure when compared to placebo. According to the announcement, partial results are being released today with additional blood pressure subset analyses, sleep quality and all other data analyses will be reported when complete. Partial results indicate that at selected times during the 24-hour study, volunteers with mild to moderate hypertension averaged as much as a 20 mmHg (i.e., 23%) decrease in BP relative to placebo, with volunteers averaging a notable reduction of 7.0% (p<0.001) in systolic pressure. To view the full press release, visit https://ibn.fm/nYtb4

Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 19 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has a collaborative research agreement with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has filed for patent protection for specific delivery of nicotine, vitamins, NSAIDs, testosterone, estrogen, cannabinoids, terpenes, PDE5 inhibitors (with brand names like Viagra), tobacco and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Tuesday's trading session at $7.02, up 11.4286%, on 4,652,172 volume with 28,260 trades. The average volume for the last 3 months is 4.652M and the stock's 52-week low/high is $3.97510004/$12.50.

Recent News

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC)

The QualityStocks Daily Newsletter would like to spotlight AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC).

AnPac Bio-Medical Science (NASDAQ: ANPC) subsidiary AnPac Bio-Medical Science (Lishui) Co. Ltd. has increased its holding in AnPai (Shanghai) Healthcare Management Consultant Co. Ltd., one of its subsidiaries; the increase came after approval was granted by the company audit committee and board of directors. The company announced that in late August 2021 it finalized the share structure registration amendment with the local Administration Management Bureau. Before making the decision, company officials conducted rigorous due diligence that included obtaining financial and legal audits and appraisals by a qualified appraiser. AnPac Bio-Medical Science is a biotechnology company with operations in China and the United States. AnPai is a distributor of AnPac Bio’s cancer test products, posting solid numbers for the past three years with consistent growth in revenues and customer base. To view the full press release, visit https://ibn.fm/GbIlC

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) is a biotechnology company focused on early cancer screening and detection. The company develops, distributes and deploys accessible early disease detection devices with an aim of changing the way people approach cancer screening. AnPac Bio-Medical is a highly innovative company and an early thought leader and developer of multi-cancer screening technology, which is gaining significant acceptance.

AnPac Bio-Medical has clinical laboratories in the United States and China, with 142 issued patents as of March 31, 2021. Its corporate headquarters is located in Shanghai, China, while its U.S. headquarters is situated in Philadelphia, Pennsylvania. The company operates two certified clinical laboratories in China and one CLIA registered clinical laboratory in the United States.

Cancer Differentiation Analysis (CDA)

Cancer Differentiation Analysis (CDA) is AnPac Bio-Medical’s approach to detecting cancer and pre-cancerous diseases. CDA uses the natural biophysical properties of blood and cellular proteins to discover cancerous environments before the tumors even form.

Most liquid-based cancer screening and detection technologies focus on biochemical signals, like conventional biomarkers and genomic signals, such as ct-DNAs and CTCs (circulating tumor cells in the blood). These typically only determine whether or not cancer has occurred at a fixed point in time.

CDA technology combines an assessment of existing biomarkers with the biophysical properties and cellular proteins that signal the lead-up to serious health conditions and cancer. It is also used to pinpoint where cancer is most likely located and predict where the risk is highest in the future – all through a standard blood test, at a competitive price point.

AnPac Bio-Medical’s CDA is powered by a database of over 200,000 samples and cases and serves as a new way to approach disease and cancer screening. The device uses an integrated system of sensors to detect several biophysical signals at the cellular, protein and molecular levels. CDA leverages a proprietary algorithm to synthesize the data, effectively generating a personalized risk assessment for evaluated patients.

Through CDA technology, AnPac Bio-Medical aims to address a number of goals, including:

  • Innovate – AnPac Bio-Medical is an innovator in the cancer screening industry, with CDA research ongoing since 2008, and commercial operations beginning in 2015. AnPac considers itself a thought leader in developing multi-cancer screening.
  • Detect – AnPac Bio-Medical detects early signals of threatening cancer and its location within the body.
  • Identify – CDA identifies the risks of up to 26 different types of cancers with high sensitivity and specificity rates.
  • Provide – The company’s platform provides multi-level, multi-parameter analysis using proprietary diagnostic algorithms, which results in accurate and easy-to-understand results.
  • Proven – A fully operational analysis of over 200,000 test samples has been run to date. CDA technology has been shown to identify pre- and early-stage cancers in patients previously diagnosed as “cancer-free” through traditional methods.
  • Biophysical Properties – CDA analyzes biophysical properties in human blood and the correlation between biophysical properties and cancer occurrence.

Market Outlook

AnPac Bio-Medical is exploring detection of other types of cancers leveraging its innovative CDA technology and multi-cancer screening and detection tests, which could open significant opportunities on the global cancer diagnostics market.

According to a report by Grand View Research, the cancer diagnostics market is expected to reach $249.6 billion worldwide by 2026 (https://nnw.fm/L7css). The market is expected to grow at a CAGR of 7% during the forecast period.

Management Team

Dr. Chris Yu is the Co-Founder and Chief Executive Officer of AnPac Bio-Medical. He has enjoyed a successful career as an innovator in life sciences, technology and engineering. Dr. Yu has worked for three U.S. Fortune 500 companies and is the first/principal inventor of over 300 patent applications spanning semiconductors, materials and life science. He has a proven history of developing cutting-edge products with long-term profit and sustainability. Dr. Yu was born to a medical doctor’s family and went to medical school. He later switched his major to physics and received his bachelor’s and master’s degrees in physics from the University of Missouri-Kansas City Campus and a doctoral degree in physics from Pennsylvania State University. Both of his dissertations addressed innovative detection techniques.

Dr. Herbert Yu is the Co-Founder and Chief Medical Officer of AnPac Bio-Medical. He is a renowned expert in molecular epidemiology, with training in medicine and chemical biochemistry. Dr. Yu has a 20-year career in leading-edge cancer research, including breakthrough work in areas of carcinogenic factors. He is a professor and research director at the University of Hawaii and an adjunct professor at Yale University. He received his bachelor’s degree in medicine from Shanghai First Medical College. Dr. Yu also received a science degree in epidemiology and a Ph.D. in clinical biochemistry from the University of Toronto.

Jingiu (Edward) Tang is the company’s Chief Financial Officer. He previously served as a global internal auditor at Natuzzi S.p.A. Mr. Tang also worked at Beijing Dongshen CPA and Shanghai De’an CPA, providing external audits, finance and tax advisory services across different industries and sectors. He is a Certified Public Accountant in Australia. Mr. Tang received his bachelor’s degree in accounting from Charles Sturt University in Australia, his MBA from Charles Sturt University, and his bachelor’s degree in law from Southwest University of Science and Technology in China.

Weidong Dai is the company’s China General Manager. He previously served as a general partner at Stirrfir Investment Management Co. Mr. Dai has also served as the chairman of RTS Management (Shanghai) Co., and as managing director of Hong Kong Pro-Health Technology Co. and Shanghai Pro-Health Medical Devices Co. He has published a number of medical research papers and research articles in professional journals. Mr. Dai was awarded the Hong Kong Industrial Award for a medical device that he led in research and development. He earned his bachelor’s degree in medicine from Anhui Medical University, a master’s degree in medicine from the Sun Yat-San University of Medicine, and an Advanced Certificate of the EMBA CEO Program from Fudan University, School of Economics.

AnPac Bio-Medical Science Co. Ltd. (ANPC), closed Tuesday's trading session at $3.67, up 4.2614%, on 81,970 volume with 448 trades. The average volume for the last 3 months is 81,970 and the stock's 52-week low/high is $3.15000009/$12.0900001.

Recent News

ISW Holdings Inc. (OTC: ISWH)

The QualityStocks Daily Newsletter would like to spotlight ISW Holdings Inc. (OTC: ISWH).

ISW Holdings (OTC: ISWH), a Nevada-based portfolio company with primary commercial-stage operations in cryptocurrency mining that is in the process of changing its name to BlockQuarry, has released additional information regarding its landmark agreement with Bitmain Technologies. Bitmain is the world’s leading producer of cryptocurrency mining hardware and a leading global cryptocurrency mining firm. The partnership between ISWH and Bitmain involves 56,000 Bitmain mining rigs pairing with 200 megawatts (“MW”) of power at ISWH’s Georgia location, which has been dubbed POD-CITY. According to the announcement, the Company anticipates having the first 20 MW of power paired with rigs and running by next month, with all 56,000 miners hooked up to all 200 MW of power and fully running by October 2022. To view the full press release, visit https://ibn.fm/5vtOh

ISW Holdings Inc. (OTC: ISWH), through its in-house initiatives and strategic partnerships, has invested in growing operations targeting the telehealth and cryptocurrency mining industries.

The company specializes in strategic brand development and early growth facilitation. Management maneuvers its proprietary companies through critical stages of market development, including conceptualization, go-to-market strategies, engineering, product integration and distribution efficiency.

Mission

The company’s core mission is to enhance these sectors by implementing innovative services and products that are ready to meet the demands of a changing world. To that end, ISW Holdings leverages its strategic expertise, resources and innovative software to establish market-leading companies and partnerships, thereby ensuring success in their chosen industries.

Cryptocurrency Mining

The start of 2021 saw a massive resurgence in interest surrounding bitcoin and cryptocurrency mining. In mid-February, bitcoin prices hit an all-time high of greater than $57,000, and heightened demand for cryptocurrency mining power has played a key role in exacerbating a global shortage of semiconductors and computer components.

With a foothold in the cryptocurrency mining space, ISW Holdings has placed significant focus on expanding its position and capitalizing on this momentum. Recent highlights include:

  • February 9, 2021: The company announced that its revolutionary Pod5 Cryptocurrency Mining Pod will be powered up into full operational launch at the Bit5ive renewable energy cryptocurrency mining facility in Pennsylvania on February 12, 2021.
  • February 11, 2021: The company announced that it is in negotiations to purchase a large number of miners (between 300 and 900) in preparation for its coming Phase 3 expansion in mining volume.
  • February 23, 2021: The company announced its entry into a comprehensive Hosting and Maintenance Agreement prior to going online with its new ASIC s17 miners.
  • March 2, 2021: The company announced that it has successfully tripled its active cryptocurrency mining fleet with the addition of two new POD5IVE datacenters.

“As we continue to bring our miners online, we want our shareholders to be able to track the expansion and profitability of the company’s mining activity given the sharp rising trend in bitcoin prices,” Alonzo Pierce, President and Chairman of ISW Holdings, stated in a news release. “It currently costs about $11K in computing power to mine a single bitcoin. Bitcoin is pricing at over five times that level, making this is an exceptional ROI opportunity, and our responsibility to our shareholders is clear: continue to invest, expand and execute.”

Business Innovations

ISW Holdings’ diverse portfolio reflects the growing demand for essential services in a dynamic modern operational landscape. Some of the company’s current holdings and partnerships include:

  • Bit5ive LLC: ISW Holdings operates a joint venture with Bit5ive, a global leader in cryptocurrency mining. The joint-venture agreement enables ISW Holdings to collaborate with the experienced team at Bit5ive to innovate the infrastructure needed to run profitable and efficient crypto mining projects.
  • Proceso LLC: ISW Holdings has partnered with Proceso LLC to create high-density processing and mobile data centers powered by renewable energy. These innovations will allow Proceso to offer lower-cost and diverse services to its clients, including hosting and colocation services to growing sectors such as the gaming industry and cryptocurrency mining.
  • PHH Health: The company’s home health division answers the growing need for home care services in a world where health care delivery is changing and an increasingly large aging community is looking for efficient and effective ways of accessing health care.
  • Volum: The company’s logistics and supply chain management division is designed with the core goal of increasing supply chain efficiency, which is recognized as one of the key aspects of successfully growing any business.

Market Opportunity

ISW Holdings’ recent activity in the cryptocurrency mining sector has positioned it to capitalize on the forecast expansion of the cryptocurrency market in the coming years. According to data from MarketsandMarkets, the cryptocurrency space was valued at $1.03 billion in 2019 and is projected to reach $1.40 billion in 2024, achieving a CAGR of 6.18% during the forecast period.

The report suggests that major drivers for this growth will be the transparency of the underlying blockchain technology, the high volume of remittances in developing countries, the high cost of international remittance, expected fluctuations in monetary regulations and sustained investment in the cryptocurrency space by venture capital firms.

Management Team

Terry Williams is the Chief Executive Officer and Director of ISW Holdings. Mr. Williams brings to the company more than 30 years of experience in accounting and information systems, logistics, insurance and transportation. With a Bachelor’s and Master’s degree in accounting and management information systems, he amassed considerable corporate experience at UPS (NYSE: UPS), where he took several logistical roles, managing more than 2,000 employees and a budget of more than $10 billion. Mr. Williams also serves as president of Airware Transportation and Logistics and Chief Financial Officer of AVI Insurance Caribbean. In 2013, he received the National Airport Minority Advisory Council Award for mastering skills in the aviation industry.

Alonzo Pierce is the company’s President and Chairman. He brings a wealth of business development and wealth management experience to the ISW team, having spent the past 20 years building recognizable brands in multiple industry sectors. Mr. Pierce has launched enterprises in life-styled brands which were delivered to high-profile, high-net worth families and individuals. He has worked in the adult beverage industry, establishing a formidable background in marketing and brand creation. Pierce has a B.A. from Baylor University and has received multiple awards in the adult beverage industry, including ‘Outstanding Sales Performance in the Southern Region’ for Sapphire Brands. Pierce also served as a national liaison to a Super-Regional Bank’s private wealth division. In addition to his for-profit endeavors, Pierce has served on multiple charitable boards, sourcing funding for JRA, food insecure families and housing insecure families.

Kristina Mahoney-Brown is Secretary, Treasurer and Director of ISW Holdings. With more than 20 years of experience providing tax and financial consulting to real estate companies, as well as investors, developers and construction companies, Ms. Mahoney-Brown has gained solid business expertise and market knowledge and prides herself on staying abreast of the latest industry trends. Her professionalism, impeccable work ethic and advanced marketing strategies have earned her the nickname ‘The Tax Diva’. Mahoney-Brown has a Bachelor’s in accounting, a Master’s in taxation and a Master’s in business administration, specializing in personal financial planning.

ISW Holdings Inc. (ISWH), closed Tuesday's trading session at $1.23, up 24.2424%, on 3,276,455 volume with 2,326 trades. The average volume for the last 3 months is 3.276M and the stock's 52-week low/high is $0.0152/$1.47000002.

Recent News

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF)

The QualityStocks Daily Newsletter would like to spotlight Red White & Bloom Brands Inc. (OTCQX: RWBYF).

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, today announced its receipt of adult use (recreational use) prequalification status pursuant to the licensing provisions of the Michigan Regulation and Taxation of Marihuana Act (“MRTMA”) and associated rules through a wholly owned operating subsidiary, RWB Michigan, LLC. According to the update, this Marijuana Regulatory Agency (“MRA”) approval represents the company’s authorization to move forward with its full operational strategy in the state of Michigan and complete the licensing process for its intended facilities. “Michigan has been one of the highest bars of entry to any market we’ve entered,” said RWB CEO and Chairman Brad Rogers. “The regulatory body has done it right, and all stakeholders should feel comfort with the level of scrutiny and governance they require to be compliant operators. This now provides a clear path for us to fully execute on our strategy of being the house of brands and being great channel partners to all of our distribution points as well as our own planned flagship retail locations.” To view the full press release, visit https://ibn.fm/Rsi47

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) is a torchbearer blazing a new frontier in American cannabis by adhering to the highest ethical, manufacturing, educational, branding and employment standards available in the industry.

Red White & Bloom is a super state operator, leveraging a sizable footprint to dominate the areas in which it operates. CEO Brad Rogers and other management members have seen the struggles of multi-state operators who have spread themselves too thin, which is why Red White & Bloom is intent on dominating each state it enters before expanding further.

Although targeting individual states in the United States, the company is headquartered in Toronto, Canada. Red White & Bloom was established after privately held MichiCann Medical Inc. merged with publicly traded Tidal Royalty in 2019.

Brands

Red White & Bloom has entered strategic brand acquisitions and partnerships aimed at helping the company expand its presence and position as one of the largest players in the United States cannabis market. Red White & Bloom is always diligently searching for brands to acquire that will provide additional value to the company and expand its national footprint.

The company’s current brand portfolio includes:

  • Platinum Premium Cannabis Products (PV): Platinum uses innovative thinking, honesty and responsibility to remain at the forefront of the cannabis industry. PV holds itself and its partners to the highest standards, providing clean and safe CBD and THC products. In the company’s press release dated January 13, 2021, it reported system-wide sales of Platinum-branded products exceeding $2.8 million for the first week of January alone.
  • High Times®: In June 2020, the company acquired the licensing rights and branding of High Times dispensaries and High Times cannabis-based CBD and THC products in Michigan, Illinois and Florida. The company also acquired branding of High Times hemp derived CBD products nationally in the United States carrying the Culture® brand.
  • Mid-American Growers: Mid-American began as a family operation in 1971 in Granville, Illinois. The original 8-acre greenhouse has expanded to a 3.6-million-square-foot, state-of-the-art technology and science facility under glass. Mid-American’s product offerings include its CBD Icy Relief Salve, CBD Icy Relief Roll-on and CBD Gummies.

Retail Focus

Red White & Bloom is working to establish a significant retail presence across multiple jurisdictions. In Michigan, the company is invested in and has the rights to acquire (subject to regulatory approvals) a licensed operator that controls the assets of 18 dispensary locations throughout the state. Red White & Bloom is also pursuing opportunities in Florida aimed at making its proposed retail footprint compelling and attractive to the majority of cannabis consumers within each state.

Cultivation

Red White & Bloom is focused on standardization and quality, with everything guided by a relentless commitment to the highest standards. The company acquired a 3.6-million-square-foot standardized facility dedicated to helping it achieve premium value for the products it intends to cultivate.

As it continues to expand, the company remains committed to the practices that have guided its success in the past, including:

  • A top-down approach to cultivation developed under the guidance of PhDs with expertise in growing principles, SOPs and, most importantly, the science behind it all.
  • Commitment to exceeding the requirement of the states in which it operates. The company cut its teeth under the world’s first national cannabis purity regime – a regime that most new markets use as a benchmark – so quality is in its DNA.
  • Science-driven production methods supported by automated, perpetual, standardized operations that enable craft cannabis-like quality at an industrial scale.

Footprint

Assuming completion of the currently proposed investments and acquisitions, Red White & Bloom will be among the cannabis market’s largest companies, joining the ranks of a select few multi-state operators dominating the industry. Red White & Bloom currently has assets (closed and in closing stages) in Michigan, Illinois, Florida, California, Oklahoma and Massachusetts.

The company’s strategic acquisition and super state operator model, combined with its commitment to top-quality product and service, position it to become a leading player in the North American cannabis market.

When evaluated beside competitors in the cannabis space, Red White & Bloom boasts an extremely attractive valuation. While large cap cannabis firms serving North American markets averaged enterprise-value-to-EBITDA multiples of 14.9x as of December 2020, Red White & Bloom’s enterprise multiple was just 3.4x, as noted in the company’s latest investor deck.

In 2020, the cannabis market worldwide was valued at $24.6 billion. This amount is expected to expand at a CAGR of 14.3% from 2021 to 2028, resulting in a market size of $84 billion in 2028 (https://nnw.fm/f09ZL). Of the 2020 valuation, the largest revenue share (91.1%) was attributed to North American consumers (https://nnw.fm/vObW6).

Management Team

Brad Rogers is the CEO and Executive Chair of Red White & Bloom. He is a visionary for the future of cannabis and CBD products in the United States market, with a proven track record of building successful and profitable businesses in the rapidly expanding and new economic sector. Mr. Rogers was a part of the team that built one of the first commercially scaled production facilities in the world for medicinal cannabis. He also served as President for one of the leading licensed producers in Canada. Both of his ventures were successful, with a combined market cap of $2 billion.

Michael Marchese is the company’s Co-Founder and Marketing Advisor. He has played a crucial role in its development and organization, overseeing capital raises, acquisition strategy and brand identity. Mr. Marchese has a strong reputation and presence in the cannabis industry. He also co-founded and directed the branding of Aleafia Health Inc., which he continues to counsel. Through his branded company, Marchese Design, he has served as a highly trusted counselor to top-level execs, including C-Suite level employees, offering insights into the process of creating, building and maintaining brand identities.

Theo van der Linde is the CFO and Director of Red White & Bloom. He is a Chartered Accountant with 20 years of experience in finance, administration and public accounting. The experience he has acquired spans multiple industries, including mining, oil & gas, financial services, retail and manufacturing. For the last nine years, he has primarily focused his career on the mining industry, working with junior exploration and producing mining companies at various stages of growth in several jurisdictions. Mr. van der Linde is also the current President of Executive Management Solutions Ltd.

Red White & Bloom Brands Inc. (RWBYF), closed Tuesday's trading session at $0.8119, up 4.8289%, on 509,637 volume with 283 trades. The average volume for the last 3 months is 509,637 and the stock's 52-week low/high is $0.330000013/$1.64999997.

Recent News

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF)

The QualityStocks Daily Newsletter would like to spotlight PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF).

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced its appointment of Fred Leigh as a director and executive chairman of the company’s board of directors. PlantX also announced that it has dissolved its advisory board, previously chaired by Leigh, and that it believes his appointment as executive chairman will mitigate effects of the dissolution while providing additional cost-savings. Leigh has robust business expertise that includes four decades of capital markets experience, having played key founding and executive roles in establishing and scaling numerous public companies. “It is amazing that someone of Mr. Leigh's stature believes in PlantX,” said PlantX Founder Sean Dollinger. “We see this as vote of confidence to have Mr. Leigh lead our company as executive chairman.” To view the full press release, visit https://ibn.fm/GnXMA.

  • PlantX’s operations are firmly anchored on three operational focal points, namely products, distribution and community
  • The company is also guided by a growth strategy, under which the e-commerce platform is the main driver of growth
  • In a recent press release, PlantX announced the launch of its redesigned Canadian website, powered by Shopify
  • According to PlantX Founder Sean Dollinger, the decision to host the e-commerce platform on Shopify is strategic and complements the company’s mission and expansion plans

As a multifaceted marketplace, PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) aims to redefine the plant-based space by providing consumers with all things plant-based across three main operational focal points — products, distribution and community.

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) aims to redefine the plant-based community through e-commerce, with a core objective of becoming the most trusted and convenient destination for people living plant-based lives. PlantX is a multifaceted marketplace providing consumers all things plant-based ranging from an efficient e-commerce experience, connecting consumers with interactive PlantX brick-and-mortar stores, and a PlantX home delivery system for products, meals, recipes and more.

PlantX is a high-growth technology company focusing on consumer-packaged goods (“CPG”) for the plant-based opportunity. The PlantX platform aims to serve as the digital face of this community with its one-stop-shop for everything plant-based, including:

  • An easy-to-use e-commerce shopping experience featuring the following:
    • Plant-based grocery items (from all your pantry needs to vitamins, cosmetics and even pet food)
    • Meal delivery with recipes created by well-known plant-based chefs throughout the world
    • Plant shop – delivering a wide variety of affordable indoor houseplants to homes across Canada and the U.S.
    • Easy to follow plant-based recipes every week
    • Partnerships with restaurants, nutritionists, chefs and brands
    • A community of like-minded individuals
  • State-of-the-art flagship PlantX locations

Since first launching in February 2020, PlantX Life has offered various services available through its comprehensive platform. This online marketplace features over 10,000 items across diverse product categories such as pantry items, beverages, personal care, pet food and indoor plants. In addition, PlantX has collaborated with renowned chefs and nutritionists to create 20 unique and pre-made meals delivered to the comfort of your own home.

Headquartered in Vancouver, Canada, PlantX’s mission is to spearhead the plant-based movement, celebrate and promote health and wellbeing, raise plant-based awareness in a hyper-palatable world, connect with global consumers and forge a welcoming plant-based community.

The company currently reports 4 million stock options and 24 million warrants outstanding, with a total of 88,832,159 shares issued and outstanding and a total market cap of $89.9 million on January 18, 2021. PlantX has continued to catalyze its capital markets dynamics by applying to list its common shares on the Nasdaq Capital Market (“NASDAQ”). The company’s common shares are eligible for electronic clearing and settlement through The Depository Trust Company (“DTC”) in the United States.

Market Outlook

With its comprehensive e-commerce platform, PlantX is strongly positioned for a prominent role in the fast-growing plant-based food market, e-commerce and the online food delivery sectors. The global plant-based food market is expected to reach $74.2 billion by 2027, expanding at a CAGR of 11.9%. Similarly, the online food delivery market has steadily grown, especially during the current pandemic. This trend seems here to stay. In the United States alone, the sector is expected to report $28.5 billion by 2024, with companies such as UberEats experiencing 152% increases in food deliveries in the summer of 2020.

Complementary to these trends, and as a result of the COVID-19 pandemic, online sales and digitization have also both grown exponentially in 2020. Grocery shopping has seen a remarkable transition to e-commerce, with online grocery sales growing by 53% in 2020. Amid the pandemic-imposed physical interactions and related consumer behavior change, large retailers have been compelled to meet this surge in e-commerce demand. For example, Whole Foods Markets has increased its online sales capacity by over 60% in 2020. The global meal kit delivery system is also becoming increasingly popular and is expected to achieve a market value of $19.92 billion by 2027, expanding at a CAGR of 12.8%.

PlantX aims to capitalize on this anticipated exponential market growth of the plant-based, e-commerce and home-delivery industries.

Digital Platform for the Plant-Based Community

The digital interface provided by PlantX spans a health and wellness initiative that offers thousands of plant-based products, meal delivery, indoor plants, recipes and a community space for those who are like-minded about plant-based products and healthy lifestyles. PlantX has been compared to Amazon, except with a focused tailored selection of plant-based offerings.

PlantX provides everything a consumer needs for plant-based living at the click of a button. With PlantX, customers can:

  • Shop
  • Find recipes
  • Read blogs
  • Join a community forum
  • Listen to podcasts
  • View cosmetics
  • Research vitamins
  • Purchase plant-based pet foods
  • Read corporate updates
  • Subscribe to an insightful newsletter

The company’s website was designed with a user-friendly interface that allows customers to visit the site and easily find what they need. Forums for communicating with a plant-based community make it easier to swap recipes or locate the best restaurants serving vegan and vegetarian-friendly cuisine.

PlantX Flagship Locations – British Columbia (Canada), San Diego (California), & the State of Israel

PlantX will link the e-commerce platform to flagship brick-and-mortar stores for a highly sensory customer experience. This is anticipated to drive corporate growth and global brand recognition.

These PlantX branded flagship locations will first launch in:

Customer engagement, education and creating a global plant-based community will be furthered through this initiative.

PlantX Restaurant Partnerships

With consumers becoming better informed and more health and environmentally conscious, a growing number of restaurants will start catering to the needs of customers who are vegan, vegetarian, have food-allergies (or specialized diets), or simply want to eat healthier.

PlantX proactively aims to support this change and help restaurants meet the needs of the plant-based community. Restaurants that want to increase revenue, drive traffic and make an impact can therefore partner with PlantX to better serve their customers by expanding and refining their menus.

Future Goals for PlantX Life

Having successfully completed all of the milestones that PlantX had set-out to achieve in the second half of 2020, PlantX strives to continue scaling through organic growth, strategic partnerships and accretive M&A opportunities. The upcoming plans from PlantX includes a global expansion strategy for distribution in North America, Europe and Israel.

Verticals launched in 2020 include:

  • New meals and programs by renowned chefs
  • Flagship PlantX locations
  • PlantX branded goods
  • United States meal delivery and LIV
  • Online peer-to-peer fitness

Management Team

Sean Dollinger, the Founder of PlantX Life Inc., has had a very active professional career that started when he was only 17. While still in college, he started a delivery service that soon became one of Canada’s largest delivery firms (before companies like Postmates and Uber Eats ever existed). In 2014, Mr. Dollinger founded Namaste Technologies, the largest international e-commerce distributor of vaporizers and accessories. He brought Namaste public and turned it into a $1.2 billion business in two years. After finding a plant-based diet himself, and seeing the massive benefits that it provided for him, he decided he wanted to find a way to give back to the community and focus on something he loves. PlantX Life was born from this desire and became his passion project. He truly walks the talk.

Julia Frank is the CEO of PlantX Life. She has an MBA in digital entrepreneurship, and, in her past roles, she set up renowned strategies for large corporations like BMW and Daimler in Germany. Beyond her professional business prowess, Ms. Frank finds tremendous joy in preparing delicious and nutritious plant-based meals and is the face of the company. She practices a healthy and active lifestyle that includes experiencing as many cultures as possible to add more knowledge of the industry at large. This globally inclusive perspective gives her the unique advantage of being able to see plant-based living from all angles.

Lorne Rapkin, CPA, CA, LPA, is the President and CFO of PlantX Life and is also a partner at Rapkin Wein LLP. He has experience with clients in almost every industry, including finance, professional services, real estate, automotive, media and manufacturing. Mr. Rapkin works very closely with investment and public firms, seeking to comply with IFRS accounting standards. His roles often require him to work with management on go-public transactions, acquisitions and mergers. His keen attention to detail is an asset to any client he works with, and PlantX is no exception.

Alex Hoffman is the company’s CMO and has spent the last 10 years in the creative field cultivating her passion for design and appreciation for beauty. This is apparent in all of the creative decisions and outcomes seen at PlantX. Her role within the company is to oversee all of the brand marketing activities, establish and execute key processes for rapid growth, and work closely with management to refine the brand’s message for key segments and emerging opportunities. She has a sharp vision for exactly what’s needed to convey the company’s core messages and principles to both the public and investors, and she is a visionary with respect to creative marketing ideas and concepts.

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), closed Tuesday's trading session at $0.375, up 4.1667%, on 517,393 volume with 271 trades. The average volume for the last 3 months is 517,393 and the stock's 52-week low/high is $0.170000001/$1.85000002.

Recent News

InnerScope Hearing Technologies Inc. (OTC: INND)

The QualityStocks Daily Newsletter would like to spotlight InnerScope Hearing Technologies Inc. (INND).

InnerScope Hearing Technologies Inc. (OTC: INND) interview with Matthew Moore, CEO by FMW Media’s New to The Street TV was announced among the broadcasting of its national syndicated shows, Monday night, September 06, 2021 at 10:30 PM PT and Tuesday night, September 07, 2021 at 10:30 PM PT on Fox Business Network .

InnerScope Hearing Technologies Inc. (OTC: INND) is a Nevada corporation incorporated on June 15, 2012, with its principal place of business in Roseville, California. The company was initially started in 2006 – operating as InnerScope Advertising Agency Inc. – to provide advertising and marketing services to retail establishments in the hearing device industry. On August 25, 2017, the company changed its name to InnerScope Hearing Technologies Inc. to better reflect its current direction as a hearing health technology company that manufactures, develops, distributes and sells numerous innovative hearing health-related products, hearing treatments and hearing solutions, direct-to-consumer (DTC) through a scalable business model.

The company is a manufacturer and a distributor/retailer of DTC, FDA (U.S. Food and Drug Administration) registered, Bluetooth app-controlled hearing aids and personal sound amplifier products (PSAPs), hearing-related treatment therapies, doctor-formulated dietary hearing supplements, proprietary CDB oil for treating tinnitus and assorted hearing and health-related products targeting approximately 70 million Americans suffering from hearing-related problems. The company’s mission is to improve the quality of life of the 70 million people in North America and the 1.5 billion people worldwide who suffer from hearing impairment and/or hearing-related issues.

The management team of InnerScope is applying decades of industry experience and believes it is well-positioned, with its innovative in-store point-of-sale Free Self-Check Hearing Screening Kiosks (“Hearing Kiosks”), to directly benefit when the Over the Counter (OTC) Hearing Aid Act (the “OTC Hearing Aid Law”) is enacted (expected in late 2021 based on the President’s Executive Order issued on July 9, 2021) The OTC Hearing Aid Law allows OTC hearing aids for perceived mild-to-moderate hearing losses to be sold in retail stores without having to see a professional. InnerScope’s Hearing Kiosk is designed to help the tens of millions of Americans with undetected/untreated mild-to-moderate hearing loss treat themselves with the company’s easy, convenient and affordable OTC hearing aids, in-store and/or online.

Industry Game-Changer – New Emerging Market with 48 Million Potential Customers

The following is sourced from The White House Fact Sheet detailing an Executive Order from President Biden aimed at saving Americans with hearing loss thousands of dollars by allowing hearing aids to be sold over the counter at drug stores:

“Hearing Aids: Hearing aids are so expensive that only 14% of the approximately 48 million Americans with hearing loss use them. On average, they cost more than $5,000 per pair, and those costs are often not covered by health insurance. A major driver of the expense is that consumers must get them from a doctor or a specialist, even though experts agree that medical evaluation is not necessary. Rather, this requirement serves only as red tape and a barrier to more companies selling hearing aids. The four largest hearing aid manufacturers now control 84% of the market.”

On July 9, 2021, President Biden noted the following in reference to his Executive Order relating to hearing aids:

“Right now, if you need a hearing aid, you can’t just walk into a pharmacy and pick one up over the counter. You have to get it from a doctor or a specialist. Not only does that make getting hearing aids inconvenient, it makes them considerably more expensive, and it makes it harder for new companies to compete, innovate and sell hearing aids at lower prices.”

“As a result, a pair of hearing aids can cost thousands of dollars. That’s a big reason why just one in seven Americans with hearing loss actually use a hearing aid.”

InnerScope Game-Changers

For InnerScope, this Executive Order could present a significant opportunity. The company is uniquely positioned with a number of strategic advantages and offerings in the space, including:

  • First to Market: Free self-check hearing screening kiosks deployed in national pharmacy chains, big-box retailers & national and local groceries chains
  • Online Hearing Screening Tests: For national retailers to use their websites to attract more customers in conjunction with the company’s in-store hearing kiosks
  • The HearIQ App for iOS and Android users: Offers a free self-check hearing test and provides a user control function for InnerScope’s Bluetooth app-controlled self-adjusting rechargeable hearing devices
  • Customer Monthly Subscription Model: Offering the lowest, most affordable monthly payment options (as low as $42 per month for pair of rechargeable, app-controlled hearing aids) for consumers to purchase hearing aids and receive free upgrades every two years.

The In-Store Hearing Screening Kiosks and Online Free Hearing Screening Tests

Innerscope’s hearing screening kiosk and online hearing screening tests offer free self-check hearing evaluation using the world’s first “Hearing Triage” artificial intelligent pattern recognition software, which has a unique ability to classify both level (degree of loss) and pattern (type of loss). In addition, the software can detect the probable location of the hearing problem and its degree of severity.

The tests are developed as a hearing wellness tool to help track hearing ability and (if tests results indicate a hearing loss) make recommendations for in-store point of sale or online purchase of one of InnerScope’s hearing devices, as well as providing recommendations to see one of the professionals in InnerScope’s local contracted network of hearing health care experts for further follow-up testing if necessary. The software also generates an audiometric report which is instantly emailed to the customer.

The HearIQ App

InnerScope is the creator of the HearIQ App, which offers free self-check hearing tests and provides a user control function for InnerScope’s line of Bluetooth app-controlled self-adjusting rechargeable hearing devices. InnerScope developed the free hearing test part of the HearIQ App to help with the early detection of hearing loss for the 1.5 billion people worldwide who have untreated hearing loss or some form of hearing issues that may be undetected and do not have access to a computer for InnerScope’s online hearing screening test.

Hearing Aid Products

Through its dedicated online store, MyHearIQ.com, InnerScope offers affordable, direct-to-consumer, Bluetooth app-controlled, self-adjusting hearing technology to empower consumers to take control of their hearing care. InnerScope’s hearing technology allows the customer in less than 10 minutes using any smartphone to personalize each hearing device to their hearing needs using an onboard in-ear custom-fit self-testing feature through the HearIQ App.

InnerScope is shifting hearing health care from traditional brick-and-mortar hearing care clinics to customers’ homes by providing a unique solution to give customers top quality, affordable access to hearing aids without the need to see a hearing professional or go to a hearing care clinic. As a result, InnerScope can deliver the same level and quality of hearing technology and expert support for the customer from their homes at a fraction of the cost of traditional channels. All InnerScope hearing aid devices are medical-grade and available with professional remote programming and support services from one of the company’s licensed hearing professionals through the HearIQ App.

Hearing & Tinnitus Dietary Supplements

InnerScope has developed a proprietary line of doctor-designed hearing & tinnitus dietary supplements to help people with hearing problems protect themselves from future hearing issues. There are currently three types of formulas to choose from, including Ear-Ring Relief for the 60 million Americans who suffer from tinnitus, HearingVite + Memory Boost for people with hearing loss and cognitive issues, and HearingVite + Multivitamin for maintaining proper hearing health and levels of nutrients.

Complete Line of Hearing Health Care Products

InnerScope offers a brand label of assorted ear care and hearing aid maintenance products. In support of overall ear health and ensuring maximum performance from its hearing aids and comfort for its customers, InnerScope provides a whole line of care items, including cleaning kits, wipes, spray and drying tablets, ear cleaner for wax removal, a natural lubricant agent for new hearing aids and hydrating lubricating ear gel.

Verified Wholesale and Direct-to-Consumer Sales

InnerScope is a verified wholesaler with Walmart for premium affordable direct-to-consumer hearing aids, personal sound amplification and hearing health accessories. InnerScope also created an easy shopping experience for its hearing and tinnitus vitamins through Walmart and Amazon Prime. With new partnerships in the works, the company aims to add other online and brick-and-mortar establishments to its vitamin distribution network in the future.

Hearing Aid Market Outlook

The global hearing aid market is expected to reach $11.02 billion by 2028, growing at a CAGR of 7.4% during the forecast period. This marks a significant increase from the $6.47 billion value reported in 2020, an increase largely driven by innovations being made in hearing aid technology (https://ibn.fm/bRWUb).

As a leading wholesale provider and direct-to-consumer business, InnerScope is positioned to disrupt the global hearing aid market. Its partnerships with some of the United States’ largest retail distributors and wholesalers are only strengthening the company’s position within the industry.

Management Team

Matthew Moore is the President and CEO of InnerScope Hearing Technologies Inc. He grew up in the hearing health industry, working alongside his grandfather through internships and mentorships. At the age of 10 years old, he became Chief Marketing Officer and Chief Operating Officer of his parent’s private hearing aid practice, the largest in Northern California and the second largest in the state. Matthew has shown his leadership ability by creating distribution partnerships with big industry names and independent retailers/pharmacies.

Kim Moore is the Chief Financial Officer of InnerScope Hearing Technologies Inc. She has worked in the hearing aid industry for over 45 years, helping her father maintain his hearing aid practice in Central Valley, California. She began working on marketing with her father at the age of eight, learning that no customer walks through the door without proper advertising and marketing. As a licensed hearing instrument specialist, Kim has given hearing tests to more than 30,000 people.

Mark Moore is the Chairman and Co-Founder of InnerScope Hearing Technologies Inc. He has over 35 years of experience in hearing aid dispensing, practice management, private label brand management and hearing aid marketing. He has personally fit hearing aids to over 10,000 hearing-impaired people. In addition, he has been responsible for developing and testing proven new industry marketing and advertising methods and best practice strategies, which has made him one of the most sought-after experts in the hearing aid industry. Mark was previously a columnist for Advanced for Audiologists, a global industry publication, and served on the American Academy of Audiology (AAA) advisory board for AudiologyNow conventions. He has also developed patented and patent-pending nutritional supplements for hearing-related issues, aural rehabilitation programs and low-level laser therapy for tinnitus and sensorineural hearing loss.

InnerScope Hearing Technologies Inc. (INND), closed Tuesday's trading session at $0.01, up 3.0928%, on 31,988,661 volume with 589 trades. The average volume for the last 3 months is 31.989M and the stock's 52-week low/high is $0.000000999/$0.097999997.

Recent News

Perpetual Industries Inc. (OTC: PRPI)

The QualityStocks Daily Newsletter would like to spotlight Perpetual Industries Inc. (PRPI).

As China is cracking down on cryptocurrency mining over concerns about environmental impact, savvy U.S. companies, including Perpetual Industries (OTC: PRPI), are looking to benefit. A recent Forbes publication highlights this opportunity, reporting that mining is about to get both easier and more profitable for North American crypto miners (https://ccw.fm/26AW1). Amid this backdrop, Perpetual Industries has been working to build an efficient, powerful network of cryptocurrency mining operations that offer environmentally friendly solutions for the sustainability of the blockchain industry (https://ccw.fm/mPiIV). “Our goal is to advance and integrate green energy power sources such as solar, wind and hydro in order to lessen the environmental impact of decentralized blockchain systems,” a recent article states, noting the company’s positioning and its research and development efforts for the creation of a proprietary system. “We are researching a new, revolutionary design for a crypto-mining farm system that optimizes the collection of green energy to produce a powerful, self-sustaining mining farm called the Green Energy Mining (‘GEM’) System.” To view the full article, visit https://ccw.fm/GyNjG

Perpetual Industries Inc. (OTC: PRPI) is an incubator for the development of innovative, energy-efficient technologies aimed at commercializing products that have the potential to impact and advance a wide range of industries on a global scale.

The company’s team of experts and trusted industry partners have the resources to provide essential components needed to take projects from their initial stages through to the end products. Perpetual Industries values strict controls and high levels of quality through all stages of research, development, manufacturing and commercialization.

Perpetual Industries was founded by President, Chairman and CEO Brent W. Bedford in 2005. It is located in Auburn, Indiana.

R&D Portfolio Overview

Perpetual Industries is expanding expertise and knowledge of energy-efficient technology by developing low-cost, green energy solutions for various industries, including artificial intelligence, blockchain mining, graphic rendering, renewable energy, cloud computing and internet of things (IoT), all while continuing research, development and commercialization of its proprietary XYO Balancing Technology in key applications.

XYO Balancing Technology

XYO Balancing Technology delivers high-performance solutions for inefficiencies that commonly affect rotating equipment, machinery and devices. It is designed to harness rotor displacement energy to move compensating masses and automatically correct for imbalances, effectively reducing vibration.

Key highlights of the company’s XYO Balancing Technology include:

  • Customized XYO balancers can be created for almost everything that rotates, providing virtually unlimited potential applications.
  • XYO Balancing Technology is optimized specifically to eliminate vibration in rotating equipment and enable environmentally responsible products to operate more efficiently.
  • Leveraging a proprietary design, XYO Balancing Technology is the result of over 25 years of research and development effort.

WindSilo – Vertical Axis Wind Turbine

Implementing its proprietary XYO Balancing Technology, Perpetual Industries’ WindSilo turbine improves balancing issues that are common in most wind turbines today. The company’s design is engineered to allow for much faster spin speeds and greater energy output.

The company believes that this innovative turbine design could eliminate the expensive traditional methods of balancing wind turbines while increasing their performance, reliability and efficiency.

In November 2020, Perpetual Industries announced that Trine University, a private post-secondary institution located in Angola, Indiana, had been awarded a grant to assist the company in the development of the WindSilo.

The XYO Washing Machine

Perpetual Industries is currently developing a proprietary domestic washing machine design implementing XYO Mechanical Balancers to dynamically compensate for variable mass imbalance during the spin cycle. The company expects these efforts to produce a number of benefits, including higher spin speeds, reduced energy consumption, decreased noise emissions and less mechanical wear & tear.

The company’s research shows tremendous market potential for a more efficient washing machine design. With an estimated 70 million washing machines produced annually and over 500 million used daily, even a small reduction in energy consumption could be pivotal. Reducing energy usage of all washing machines by just 15% would save enough energy to power the city of Milan. Perpetual Industries’ energy efficient design is expected to reduce energy usage by up to 50%.

Prototype testing of Perpetual Industries’ design has established the XYO Washing Machine as highly effective at reducing vibration when built into the spin basket assembly.

Green Energy Mining System

Using its expertise and knowledge of environmentally friendly technologies, Perpetual Industries is developing low cost, environmentally responsible energy solutions for powering large scale blockchain mining operations.

The company’s Green Energy Mining (GEM) System is being hailed as the next generation of energy efficient cryptocurrency mining. Powered by renewable & surplus energy sources such as wind, solar, natural gas, wind and geothermal that utilize battery storage technology, the platform addresses rising demand for computing power.

Renewable Energy Market Outlook

The global renewable energy market was valued at $928 billion in 2017 and is expected to continue expanding at a CAGR of 6.1%, resulting in a value of $1.5 trillion by 2025, according to Allied Market Research (https://ibn.fm/C06xF). Hydroelectric power is projected to be the most lucrative segment of the entire global renewable energy industry, followed by the wind, bioenergy, solar and geothermal segments.

Worldwide Auctioneers Acquisition

In January 2021, Perpetual Industries announced its acquisition of The Worldwide Group LLC, operating as Worldwide Auctioneers.

Worldwide Auctioneers is a U.S.-based boutique auction firm specializing in the sale and acquisition of classic vintage motorcars at auction around the globe. With an impressive 20-year history and a talented team, Worldwide offers an extensive range of personalized services to collectors, including private sales, appraisal, collection direction and consultancy, estate planning and asset management.

Perpetual Industries expects Worldwide to benefit from multiple channels of collaboration moving forward, particularly within the company’s blockchain division.

Classic Car Market Outlook

The U.S. classic car market has recorded steady expansion over recent years, accounting for revenue of approximately $12.63 billion in 2020, according to Statista (https://ibn.fm/Fydhj). The same report forecasts growth to $15.52 billion by 2023, representing a CAGR in excess of 7 percent. Classic car dealers in the U.S. have cornered a significant portion of this market opportunity. According to data from IBISWorld (https://ibn.fm/k30F5), the market for classic car dealers in the U.S. was valued at $2.1 billion in 2021, achieving a CAGR of 1.5% from 2016 to 2021, despite the challenges associated with the COVID-19 pandemic.

Management Team

Brent W. Bedford is the President, Chairman, CEO and founder of Perpetual Industries. He has held these roles continuously since founding the company in January 2005. He has a deep understanding of every aspect of the company’s business, products and markets. He also has experience developing corporate strategies, assessing emerging industry trends and carrying out business operations. Mr. Bedford has a strong background in mechanical applications, with expertise in finance, private startups, public startups and corporate turnarounds.

Carl Dilley is Director and COO of the company. He is a career entrepreneur who has served as a C-level officer in many different companies across multiple industries. Mr. Dilley has been instrumental in taking over 400 companies public. He has been involved in the investment industry since 1983. He has held FINRA series 24, 66 and 7 Securities licenses, allowing him to perform retail, investment, banking and new listing services functions.

William Griffin Thomas, CPA, is the company’s CFO. He holds a Bachelor of Science in Accounting from the University of Tampa and a Bachelor of Science in Agribusiness from the University of Florida. Mr. Thomas is a licensed CPA with over 19 years of experience spanning both the private and public sectors, as well as time with non-profits. His expertise includes auditing, budget analysis, fixed assets, financial modeling, SEC financial reporting, GAAP compliance and fair value measurements.

Perpetual Industries Inc. (PRPI), closed Tuesday's trading session at $0.2199, even for the day. The average volume for the last 3 months is 10,952 and the stock's 52-week low/high is $0.063000001/$0.925000011.

Recent News

First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF)

The QualityStocks Daily Newsletter would like to spotlight First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF).

Last week, the price of aluminum hit a new three-year high as concerns about supplies from China, which is the world’s top producer of the metal, increased after the Xinjiang region in the country began imposing output curbs on smelters. For example, last Friday, benchmark aluminum on the London Metal Exchange had increased by 1.5%, hitting almost $2,670 by noon. Earlier in the session, prices had gone up to $2664.50, which is the metal’s highest price since April 2018. On the Shanghai Futures Exchange, the price of aluminum set a new record, with the last time prices had gone that high being August 2008. An aluminum trader is quoted, noting that the significant increase in price was caused by output limits in China, which were mainly imposed in an attempt to cut down on emissions. The direction of the price of aluminum is likely to favor industrial and base metals extractors such as First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF) because high prices often translate to a better return for company investors.

First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF) is a publicly traded Canadian mineral exploration company. Its primary focus is on developing a multi-commodity mineral property portfolio by identifying, acquiring and exploring North American mineral prospects in the precious metal, base metal and industrial metals sectors.

Headquartered in Vancouver, the company (formerly known as “Agave Silver”) was first incorporated on October 12, 1966.

Core Properties – Augustus Lithium and Titan Gold

Located in Landrienne & Lacorne-Townships, Quebec, Canada, in an active lithium exploration/mining area, the Augustus Lithium Property and surrounding claims total 14,367.71 hectares . It is equipped with excellent infrastructure support, including a road network, railway, electricity, water and trained manpower available locally.

Other highlights of the Augustus Lithium Property include:

  • Geologically similar to Sayona Mining’s Authier Lithium project and Mine Quebec Lithium project located 6-12 km away.
  • Documented historical drilling over 10,000m in 62 drill holes, worth over $2 million in present day exploration expenditures.
  • Two prominent lithium and one silver prospects located on the property.
  • A potential high grade lithium resource target of 4 million tonnes at 1% lithium oxide (Li2O).
  • Potential for large volume low grade bulk tonnage near surface.
  • Two phase exploration work program includes: data compilation, geological mapping, trenching and sampling in Phase 1 (estimated cost $191,418) and diamond drilling, metallurgical testing and resource estimation in Phase 2 (estimated cost $1,166,963).

The Titan Gold Property is located in the Detour-Fenlon Greenstone Belt of east-central Quebec and is comprised of 80 mining claims totaling 4,334 hectares.

Other highlights of the Titan Gold Property include:

  • The Detour-Fenlon Greenstone Belt is host to the Detour Mine containing 20 million ounces of gold. The Fenlon Project of Wallbridge Mining has also reported strong high-grade gold intercepts and a successful high-grade (18.49 g/t Au) bulk sample.
  • Hosted within a structurally active geological environment with several northwest trending deformation zones which are splays off the Sunday Lake Deformation Zone – all key ingredients to the gold mineralization in the area.
  • The property has seen little historical exploration yet sits within what is becoming a prolific recognized gold camp.

Non-Core Properties – Kokanee Creek Gold and Scramble Mine Properties

The Kokanee Creek Gold Property consists of three mineral claims covering approximately 1,590.29 hectares in the Nelson Mining Division in British Columbia.

Other highlights of the Kokanee Creek Gold Property include:

  • Gold mineralization indicated in surface samples from historical work since 1979.
  • Subsurface gold mineralization discovered in drill holes.
  • Continuity of mineralized zones indicated through geological mapping, geochemical and geophysical survey.
  • Past producing mines in the vicinity, including the Molly Gibson and the Alpine deposits.
  • Historical production reported for the Molly Gibson Mine from 1909-1940 was at an average grade of 36.1 g/t Au and 15.3 g/t silver, with recent exploration returning samples running up to 270 g/t Au.
  • Revived exploration on the Alpine deposit area has reported a 2018 inferred resource of 142,000 oz at 16.52 g/t Au using a cut-off grade of 5.0 g/t.

First Energy Metals also holds an option to acquire a 100% interest in the Scramble Mine Gold property, located approximately 8 km east of the town of Kenora in Northwestern Ontario. The mine was discovered in 1894 but remained essentially dormant until 1984, when Boise Cascade Canada Ltd. commenced an evaluation of the property. Since 1984, approximately 5,200 meters of diamond drilling, 250 meters of surface stripping with sampling and 450 meters of underground development have taken place at the property.

Other highlights of the Scramble Mine Property uncovered as part of the company’s 2020 prospecting and sampling programs include:

  • Average value of gold in surface samples is 29.34 grams per tonne (1.03 ounces per tonne).
  • Gold assays ranged from 5.03 grams per tonne (0.18 oz/t) to 82.30 grams per tonne (2.90 oz/t), with two samples assayed over 2 oz/t.
  • All samples assayed over 5 grams per tonne gold.

Market Outlook

The global precious metals market was valued at $193.3 billion in 2020 and is expected to grow at a CAGR of 9%, resulting in a market valuation of $362.1 billion by 2027 (https://ibn.fm/WvN9Z).

The global lithium metal market was valued at $534.6 million in 2020. Through 2027, it is expected to grow at a CAGR of 9.6%, resulting in a forecast valuation of $926.6 million (https://ibn.fm/xBXcx).

First Energy Metals is well positioned to leverage growth opportunities in these expanding sectors through exploration of both its core and non-core properties.

Management Team

Gurminder Sangha is the Chief Executive Officer and Director of First Energy Metals Ltd. He is experienced in the financial industry, focusing on providing advisory-level services to privately and publicly traded companies. Mr. Sangha brings over 18 years of diverse experience related to financial management, business leadership and corporate strategy to his role with First Energy Metals. During his tenure as a board member for various publicly traded companies, he has led initiatives related to corporate finance, business development and corporate governance. Mr. Sangha has an MBA from both Queens University and Cornell University.

Jurgen Wolf is the Chief Financial Officer and Corporate Secretary for First Energy Metals Ltd. He has been involved in the oil and gas industries for over 15 years, assisting public companies with administration and investor relations. Mr. Wolf was educated in Germany and immigrated to Canada in 1953. From 1958 to 1982, he owned and operated pre-cast concrete factories in Calgary and Vancouver. From 1982 to 2002, Mr. Wolf owned and operated J.A. Wolf Projects Ltd., a commercial construction company. He is the previous President and Director of the former US Oil and Gas Resources Inc., which amalgamated to form Petrichor Energy Inc. in 2005. Mr. Wolf retains director roles with several public companies.

First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF), closed Tuesday's trading session at $0.1967, even for the day, on 10 volume. The average volume for the last 3 months is 10 and the stock's 52-week low/high is $0.086999997/$0.45719999.

Recent News

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF)

The QualityStocks Daily Newsletter would like to spotlight FuelPositive Corp. (NHHHF).

  • FuelPositive’s patent-pending first-of-its-kind system features an entirely non-polluting process of ammonia (“NH3”) production, using 30% less energy than traditional methods
  • Carbon-free NH3 contains 65% more hydrogen than highly compressed hydrogen and addresses challenges associated with storing and distributing hydrogen
  • Through its proprietary system, which stores hydrogen in carbon-free ammonia, the company is making possible the green hydrogen economy, with hydrogen able to be efficiently used for energy storage, long-distance transportation of energy, as fuel for internal combustion engine vehicles, and for other applications

We’ve all heard about the hydrogen economy. So why isn’t it happening?
In 2019, the transportation sector generated 29% of the total greenhouse gas emissions in the United States, the highest of the main economic sectors (https://ibn.fm/Jy6VS). According to 2020 statistics from the U.S. Energy Information Administration (“EIA”), gasoline accounted for 56% of the country’s transportation energy use, while diesel was responsible for 24%. In total, petroleum products accounted for a whopping 90% of the energy use (https://ibn.fm/7h2gQ), demonstrating the heavy reliance on these fossil fuels despite the growing availability of electric vehicles and all the talk about the hydrogen economy. The hydrogen economy envisions a future where carbon-free hydrogen is used for energy storage, long-distance transportation of energy, and as fuel for vehicles and heat generation. With the heightened consciousness around emissions spearheaded by governments setting net-zero greenhouse emission targets, carbon-free “green” hydrogen is emerging as a key piece of the zero-emissions puzzle. As a fuel, hydrogen has no rival — it burns cleanly and produces more power per unit of weight than gasoline or diesel or even lithium-ion batteries. But moving to the hydrogen economy is not as simple as it sounds. There are practical problems that have so far prevented its implementation. FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF), a company committed to clean energy solutions, is making the green hydrogen economy possible through its proprietary carbon-free ammonia (“NH3”) system.

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF) is a growth stage company focused on licensing, partnership and acquisition opportunities building upon various technological achievements. The company is committed to providing commercially viable and sustainable clean energy solutions, including carbon-free ammonia (NH3), for use across a broad spectrum of industries and applications.

FuelPositive is headquartered in Toronto, Canada.

Hydrogen Economy Problems and FuelPositive’s Carbon-Free Technology

The hydrogen economy is currently facing many challenges. Traditional NH3 manufacturing exists on a massive scale, but centralized facilities result in some of the world’s most concentrated CO2 emissions. In total, an estimated 200 million metric tonnes of NH3 are consumed each year, with greater than 80% utilized by the agricultural sector. NH3 is also being positioned as a viable alternative to fossil fuels.

FuelPositive’s flagship carbon-free ammonia technology provides an innovative solution to these environmental concerns. Developed by Dr. Ibrahim Dincer and his team, the company’s platform allows for the in-situ production of NH3 in an entirely sustainable manner, using only water, air and sustainable electricity.

The production of hydrogen is energy intensive, but it is just one variable hindering the growth of the hydrogen economy. Other hurdles include:

  • Storage – The storage of hydrogen by compression or liquification are both cost prohibitive and unsustainable.
  • Distribution – The distribution network for effective hydrogen deployment has yet to be developed, as the extreme high-pressure distribution requirements to transport hydrogen would result in enormous infrastructure costs.
  • End Use – R&D on the transportation-related end use applications for hydrogen is in its infancy, but almost any vehicle on the road today can be easily converted to run on NH3 at a considerably lower cost per mile traveled when compared to traditional fossil fuels.

A key benefit of FuelPositive’s patent-pending, first-of-its-kind carbon-free NH3 technology is its flexibility. The process allows for small, medium or large-scale production of NH3 on location, minimizing or even eliminating the challenges and volatility associated with storage and transportation to end use. As such, with an appropriately sized FuelPositive system and access to renewable energy, the end use applications for the company’s platform are nearly infinite.

Manufacturing Partnership

On May 19, 2021, FuelPositive announced its selection of National Compressed Air Canada Ltd. (“NCA”) to undertake manufacturing of the company’s Phase 2 hydrogen-ammonia synthesizer commercial prototype systems for carbon-free ammonia production.

In a news release detailing the partnership, FuelPositive CEO Ian Clifford noted, “This critical milestone for FuelPositive will confirm the broad application potential for our technology and is the backbone of our Carbon-Free Hydrogen-NH3 offering. Partnering with the knowledgeable and experienced team at NCA on this commercialization project will bring our development-stage program to life.”

Global Ammonia Market Outlook

The global ammonia market was valued at $52.71 billion in 2017 and is forecast to reach $81.42 billion by 2025, growing at a CAGR of 5.59%, according to data from Fior Markets (https://ibn.fm/1OfOB).

The agricultural industry consumes more than 80% of global NH3. Smaller percentages can be attributed to the waste, water treatment, refrigerants, antiseptic, textile, mining and pharmaceutical industries.

One of the most polluting industries on the planet consists of conventional agribusinesses. These polluters are responsible for more greenhouse emissions per year than transportation. This is where FuelPositive’s technology is expected to be extremely beneficial.

Management Team

Ian Clifford is Director, CEO and Founder of FuelPositive Corp. He has over 25 years of experience in the fields of technology and marketing and has successfully led the company to global brand recognition through its unique energy solutions. Since 2006, Mr. Clifford has raised over $50 million in equity financing for FuelPositive. He also co-founded digIT Interactive, a full-service internet marketing company serving Fortune 500 clients, which he sold at the peak of the market in 2000.

Greg Gooch serves as a Director and President of FuelPositive. His multifaceted career in the electronics and finance industries has positioned him as a key advisor and funding partner to start-ups and new technology companies for over 40 years. Mr. Gooch has been involved with FuelPositive since its early days and has remained a significant supporter and consultant to the company over the years. He has a bachelor’s from McGill University and an MBA from the University of Western Ontario.

Dr. Ibrahim Dincer is a scientific advisor to FuelPositive and is recognized as a pioneer and international leader in the area of sustainable energy technologies. Along with his team, Dr. Dincer invented the modular carbon-free ammonia (NH3) production technology that FuelPositive is commercializing. His area of specialty covers various topics including ammonia, hydrogen energy and fuel cells; renewable energy systems; energy storage systems and applications; carbon capturing technologies, and integrated and hybrid energy systems He is currently managing an exemplary team of researchers in this commercialization project.

Marek Warunkiewicz is the company’s Communications & Branding Specialist. He brings more than 40 years of entrepreneurial expertise to the FuelPositive team, having held marketing, branding, advertising, project management and graphic design positions with various companies. Mr. Warunkiewicz has successfully created business-to-business marketing and advertising campaigns for a diverse group of clients ranging from high-tech to agriculture. He co-founded digIT Interactive and ZENN Motor Company alongside Ian Clifford.

Luna Clifford is the Director of Communications for FuelPositive. She has over 10 years of experience as a business owner and advisor, helping build and operate several successful start-up enterprises while managing complex stakeholder relationships. Ms. Clifford excels in strategic planning and team building, and she has completed extensive studies in the fields of communications and health care.

FuelPositive Corp. (NHHHF), closed Tuesday's trading session at $0.145, even for the day, on 315,513 volume with 84 trades. The average volume for the last 3 months is 315,513 and the stock's 52-week low/high is $0.0216/$0.326000005.

Recent News

reAlpha

The QualityStocks Daily Newsletter would like to spotlight reAlpha

reAlpha, a cutting-edge technology company launching an innovative platform empowering everyone to invest in the $1.2 trillion short-term rental market, has announced its new partnership with Carthagos, a global design and product studio specializing in the strategic development of brands and digital products. According to the update, reAlpha has taken 25% equity in Carthagos, and reAlpha’s Chief Marketing Officer, Christie Currie, will join Carthagos’ board of directors. This partnership is in addition to the investment in Naamche that reAlpha announced recently.

reAlpha is the Robinhood of Airbnb investments, representing the intersection of modern technology and lasting assets. A new wave of investment opportunities in real estate has emerged, and Airbnb short-term rentals are changing hospitality and travel on a global scale. Previously, only accredited investors have had access to the best real estate deals, but reAlpha is democratizing this lucrative new model, empowering anyone to generate wealth as a reAlpha member. reAlpha uses its proprietary, disruptive technologies to level the playing field, unraveling the industry’s high barriers to entry and bringing the power of real estate investing to the “99 percent.”

The company’s unique model allows investors to benefit from both the superior returns of short-term rental income and increases in property value through renovation and appreciating markets. reAlpha likens this double investment return to seeing two desserts on a dinner menu and ordering both.

The company seeks to open up access to real estate investing by letting regular people buy fractional ownership of short-term rentals using reAlpha’s smartphone app. The reAlpha app simplifies the real estate investing process. In the app, investors can check out the company’s most current properties offered for investment. If they choose to invest, they become members of a syndicate invested in a specific short-term rental property. Syndicate members receive quarterly dividend payments from rental revenue generated by the property in which they invested. The reAlpha model merges the most historically stable asset – real estate – with technology and the sharing-economy business model of the future – Airbnb.

The company handles all property management functions and believes short-term rentals are no longer purely transactional and occupancy-driven. reAlpha reimagines the entire guest experience end-to-end to make sure the reAlphaHouse is the ultimate on-demand rental property. The company plans to implement various technologies, including smart locks, voice-activated electronics, home automation systems, and innovative furnishings, to create an unparalleled guest experience. When guests have exceptional stays, investors enjoy maximized profits.

How it Works

reAlpha has identified specific markets in which to purchase short-term rentals across the globe. The company prefers to buy 100 to 500 properties in each market. reAlpha uses artificial intelligence technology, dubbed reAlphaBRAIN, to select “unicorn properties,” the best available opportunities in the market for investment. The AI software can quickly evaluate thousands of property listings based on 25+ factors and assign each a reAlphaScore, projecting how Airbnb Viable the property is, as well as its projected value in the housing market.

For a minimum investment of $2,500, an investor can purchase equity in a specific reAlpha property, similar to how they would buy stock or shares in a company. reAlpha matches the investor with other like-minded backers to form a syndicate, so together they can cover a down payment on the selected property. Investment properties usually require a down payment of 25 percent of the purchase price, but, with reAlpha properties, the down payment is only 10 percent because of the company’s relationships with lenders, making the initial investment more affordable.

reAlpha maintains a majority stake in each investment syndicate, retaining 51 percent ownership in each purchased property and ensuring their interests are always aligned with investing members. Properties are typically refinanced after 12 to 16 months, freeing equity for reinvestment in additional properties. The company uses its AI software to predict optimum timing to sell properties in order to extract maximum value for investors. Gains are reinvested in additional properties. However, reAlpha also believes that real estate investing is more than financial returns. It includes the pride of ownership and the freedom of financial security. reAlpha members have access to their property when it is not rented out on Airbnb. The company is driven every day to create not only lucrative returns for its members but also to deliver exceptional experiences and positive impact in the communities in which reAlpha lives and operates.

 

Market Outlook

There are an estimated 7.4 million short-term rental properties worldwide. The total asset value of this global market is projected at $1.2 trillion. In the U.S. there are about 1.8 million short-term rental properties. These have an estimated asset value of $933 billion. Brain Chesky, the CEO of Airbnb, recently stated that there is a shortage of properties to meet demand and that the company will need “millions of more hosts.” reAlpha is projecting that the company and its investors will own 5,000 short-term rental investment properties by 2025. reAlpha forecasts annual revenue of $434 million by 2025.

Management Team

Giri Devanur is the CEO and co-founder of reAlpha. Prior to founding reAlpha, he served as president and CEO of enterprise software company Ameri100 Inc. from its founding in 2013. He scaled Ameri100 from zero to $50 million in revenue and took the company public in 2017. That same year, he was named E&Y Entrepreneur of the Year. He immigrated to the U.S. with virtually no possessions and $65 in the bank. He earned a Master’s in Technology Management from Columbia University, where he continues to mentor aspiring entrepreneurs.

Monaz Karkaria is the COO and co-founder of reAlpha. Prior to reAlpha, she founded real estate management firm Ben Zen Properties LLC. She has also worked in branch operations for Citibank. Before her involvement in Citibank, she worked at Berlitz in Sao Paulo, Brazil, as an ESL business coach and consultant for various international business clients like GE, Google, PepsiCo and others. She began her career in sales and marketing at Smith & Nephew Dubai. She is also a popular real estate coach and speaker.

Mike Logozzo is the CFO of reAlpha. Prior to joining the company, he served as Managing Director, Americas for innovation advisory firm L Marks. Before that, he was General Manager, Financial Services Operations, Americas Region for BMW Group Financial Services, where he also held Special Projects Manager and CIC Strategy Manager positions.

Christie Currie is the CMO of reAlpha. Previously, Christie launched her own business in the MedTech space, Zandaland, where she worked closely with large enterprises and health care systems. Currie’s work in the startup community led her to London-based corporate innovation firm L Marks, where she led world-leading corporations in retail, supply chain and logistics, and health care to identify strategic areas of need and successfully engage industry-disrupting startups. Currie has mentored hundreds of these startups, helping them to align their technology solutions with market needs.


Recent News

chart

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

  • SRAX offers a premier investor intelligence and communications platform branded Sequire for clients to track investors’ behavior and trends, and engage shareholders
  • SRAX is hosting its first Sequire EdTech Conference on September 13, 2021, which will include corporate presentations, keynote speakers and more
  • EdTech is a thriving marketplace forecast to grow from $85 billion in 2020 to $382 billion in 2028

Technology continues to be the hottest market around as evidenced by the NASDAQ Composite Index steadily setting new record highs as it charts a course toward 15,500. Within that market, education technology, or EdTech for short, is shining bright with SRAX (NASDAQ: SRAX) this month bringing together some of its stars in the first ever Sequire EdTech Conference, a one-day investor event featuring prominent virtual work and remote learning companies.

SRAX (NASDAQ: SRAX) is a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform. SRAX has upgraded the user experience on Sequire to add a new Investment Advisor feature and on-demand presentation replays from the 2021 Sequire Blockchain Conference. The event, hosted on SRAX’s investor analytics platform, was a huge success. “This conference was one of the best we’ve ever put on,” said SRAX CEO and Founder Christopher Miglino. “The content was educational, and the companies that presented are paving the way for a crypto future. If you have not already watched the presentations and want to be educated on what companies are doing in the space, I would encourage you to view these amazing panels and presentations.” According to a recent article, “the conference featured keynotes by prominent thought leaders and industry royalty.” To view the full article, visit https://ibn.fm/J2YSU

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Tuesday's trading session at $5.3, off by 0.934579%, on 301,279 volume with 2,735 trades. The average volume for the last 3 months is 301,229 and the stock's 52-week low/high is $2.05999994/$7.28999996.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Wednesday's trading